TNF-α signalling and inflammation: interactions between old acquaintances
Introduction Inflammation is a very important part of innate immunity and is regulated in many steps. One such regulating step is the cytokine network, where tumor necrosis factor α (TNF-α) plays one of the most important roles. Methods A PubMed and Web of Science databases search was performed for...
Saved in:
| Published in | Inflammation research Vol. 62; no. 7; pp. 641 - 651 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Basel
SP Birkhäuser Verlag Basel
01.07.2013
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Introduction
Inflammation is a very important part of innate immunity and is regulated in many steps. One such regulating step is the cytokine network, where tumor necrosis factor α (TNF-α) plays one of the most important roles.
Methods
A PubMed and Web of Science databases search was performed for studies providing evidences on the role of TNF-α in inflammation, apoptosis, and cancer.
Results and Conclusion
This review concisely summarizes the role of this pro-inflammatory cytokine during inflammation. It is focused mainly on TNF-α intracellular signaling and its influence on the typical inflammatory features in the organism. Being one of the most important pro-inflammatory cytokines, TNF-α participates in vasodilatation and edema formation, and leukocyte adhesion to epithelium through expression of adhesion molecules; it regulates blood coagulation, contributes to oxidative stress in sites of inflammation, and indirectly induces fever. The connection between TNF-α and cancer is mentioned as well. |
|---|---|
| AbstractList | Introduction: Inflammation is a very important part of innate immunity and is regulated in many steps. One such regulating step is the cytokine network, where tumor necrosis factor alpha (TNF- alpha ) plays one of the most important roles. Methods: A PubMed and Web of Science databases search was performed for studies providing evidences on the role of TNF- alpha in inflammation, apoptosis, and cancer. Results and Conclusion: This review concisely summarizes the role of this pro-inflammatory cytokine during inflammation. It is focused mainly on TNF- alpha intracellular signaling and its influence on the typical inflammatory features in the organism. Being one of the most important pro-inflammatory cytokines, TNF- alpha participates in vasodilatation and edema formation, and leukocyte adhesion to epithelium through expression of adhesion molecules; it regulates blood coagulation, contributes to oxidative stress in sites of inflammation, and indirectly induces fever. The connection between TNF- alpha and cancer is mentioned as well. Introduction Inflammation is a very important part of innate immunity and is regulated in many steps. One such regulating step is the cytokine network, where tumor necrosis factor α (TNF-α) plays one of the most important roles. Methods A PubMed and Web of Science databases search was performed for studies providing evidences on the role of TNF-α in inflammation, apoptosis, and cancer. Results and Conclusion This review concisely summarizes the role of this pro-inflammatory cytokine during inflammation. It is focused mainly on TNF-α intracellular signaling and its influence on the typical inflammatory features in the organism. Being one of the most important pro-inflammatory cytokines, TNF-α participates in vasodilatation and edema formation, and leukocyte adhesion to epithelium through expression of adhesion molecules; it regulates blood coagulation, contributes to oxidative stress in sites of inflammation, and indirectly induces fever. The connection between TNF-α and cancer is mentioned as well. Inflammation is a very important part of innate immunity and is regulated in many steps. One such regulating step is the cytokine network, where tumor necrosis factor α (TNF-α) plays one of the most important roles. A PubMed and Web of Science databases search was performed for studies providing evidences on the role of TNF-α in inflammation, apoptosis, and cancer. This review concisely summarizes the role of this pro-inflammatory cytokine during inflammation. It is focused mainly on TNF-α intracellular signaling and its influence on the typical inflammatory features in the organism. Being one of the most important pro-inflammatory cytokines, TNF-α participates in vasodilatation and edema formation, and leukocyte adhesion to epithelium through expression of adhesion molecules; it regulates blood coagulation, contributes to oxidative stress in sites of inflammation, and indirectly induces fever. The connection between TNF-α and cancer is mentioned as well. Inflammation is a very important part of innate immunity and is regulated in many steps. One such regulating step is the cytokine network, where tumor necrosis factor α (TNF-α) plays one of the most important roles.INTRODUCTIONInflammation is a very important part of innate immunity and is regulated in many steps. One such regulating step is the cytokine network, where tumor necrosis factor α (TNF-α) plays one of the most important roles.A PubMed and Web of Science databases search was performed for studies providing evidences on the role of TNF-α in inflammation, apoptosis, and cancer.METHODSA PubMed and Web of Science databases search was performed for studies providing evidences on the role of TNF-α in inflammation, apoptosis, and cancer.This review concisely summarizes the role of this pro-inflammatory cytokine during inflammation. It is focused mainly on TNF-α intracellular signaling and its influence on the typical inflammatory features in the organism. Being one of the most important pro-inflammatory cytokines, TNF-α participates in vasodilatation and edema formation, and leukocyte adhesion to epithelium through expression of adhesion molecules; it regulates blood coagulation, contributes to oxidative stress in sites of inflammation, and indirectly induces fever. The connection between TNF-α and cancer is mentioned as well.RESULTS AND CONCLUSIONThis review concisely summarizes the role of this pro-inflammatory cytokine during inflammation. It is focused mainly on TNF-α intracellular signaling and its influence on the typical inflammatory features in the organism. Being one of the most important pro-inflammatory cytokines, TNF-α participates in vasodilatation and edema formation, and leukocyte adhesion to epithelium through expression of adhesion molecules; it regulates blood coagulation, contributes to oxidative stress in sites of inflammation, and indirectly induces fever. The connection between TNF-α and cancer is mentioned as well. |
| Author | Zelová, Hana Hošek, Jan |
| Author_xml | – sequence: 1 givenname: Hana surname: Zelova fullname: Zelova, Hana – sequence: 2 givenname: Jan surname: Hosek fullname: Hosek, Jan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23685857$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkbtOwzAUhi1URCnwACwoI0vg2E5jmw1VlIsQLCCxWb6lSpU4YCdCPBYvwjPhUFgYYLF95O__h_PN0MR33iF0iOEEA7DTCAAY54BpDiVNxxbaxQWBXAB_mqQ3EJpTTmGKZjGuE80JJztoSmjJ53zOdtHNw90y_3jPYr3yqmlqv8qUt1ntq0a1rerrzp-lqXdBmXGImXb9q3M-6xqbKfMyqPSrvHFxH21Xqonu4PveQ4_Li4fFVX57f3m9OL_NDWWsz1VZagpgdSW0KbTVlleGKFFxTHAlBNbEcKOVMMJSg61wFlujGejCFcwxuoeON73PoXsZXOxlW0fjmkZ51w1R4gKTORS04P-jtGScCTGHhB59o4NunZXPoW5VeJM_q0oA2wAmdDEGV0lT918L6oOqG4lBjlLkRopMUuQoRY7V-Ffyp_yvDNlkYmL9ygW57oaQFMU_Qp-PjZ8y |
| CitedBy_id | crossref_primary_10_1016_j_taap_2017_09_023 crossref_primary_10_3390_toxins13020142 crossref_primary_10_1134_S0006297918060081 crossref_primary_10_1371_journal_pone_0247550 crossref_primary_10_3390_molecules24162883 crossref_primary_10_1186_s12989_016_0130_z crossref_primary_10_3389_fnmol_2020_00017 crossref_primary_10_3389_fped_2025_1520804 crossref_primary_10_1155_2022_2944156 crossref_primary_10_1016_j_ijpharm_2021_120381 crossref_primary_10_1080_08923973_2021_2023173 crossref_primary_10_1186_2213_0802_1_15 crossref_primary_10_1016_j_intimp_2022_108705 crossref_primary_10_1093_rb_rbae057 crossref_primary_10_1177_1074248418778836 crossref_primary_10_2174_1871530320666200423095700 crossref_primary_10_1016_j_bcp_2021_114884 crossref_primary_10_1016_j_molstruc_2023_136851 crossref_primary_10_1016_j_pnpbp_2016_09_004 crossref_primary_10_1155_2021_6698345 crossref_primary_10_18632_oncoscience_81 crossref_primary_10_1016_j_ajp_2023_103636 crossref_primary_10_1038_s41598_023_49488_1 crossref_primary_10_1016_j_bbih_2021_100228 crossref_primary_10_1590_s2175_97902022e191070 crossref_primary_10_1189_jlb_3A0916_388RR crossref_primary_10_1186_s12931_014_0133_y crossref_primary_10_3389_fmicb_2022_1036042 crossref_primary_10_1002_jbt_22733 crossref_primary_10_1016_j_envres_2024_119034 crossref_primary_10_3390_ijms19123746 crossref_primary_10_3389_fphar_2024_1427340 crossref_primary_10_3390_ijms241311086 crossref_primary_10_3390_molecules27082596 crossref_primary_10_1016_j_procbio_2020_06_012 crossref_primary_10_3389_fimmu_2021_622471 crossref_primary_10_3892_mmr_2019_10278 crossref_primary_10_1016_j_ijbiomac_2024_138215 crossref_primary_10_1093_abbs_gmab019 crossref_primary_10_1007_s43450_021_00167_0 crossref_primary_10_1016_j_fct_2024_114838 crossref_primary_10_1016_j_genrep_2020_100966 crossref_primary_10_1016_j_jinorgbio_2021_111587 crossref_primary_10_1016_j_ecoenv_2023_115325 crossref_primary_10_1016_j_envres_2017_06_016 crossref_primary_10_1039_D1RA07751A crossref_primary_10_3389_fcvm_2022_948006 crossref_primary_10_3390_ijms25147762 crossref_primary_10_3390_ma15196683 crossref_primary_10_3389_fimmu_2023_1289744 crossref_primary_10_1155_2022_8372707 crossref_primary_10_1186_s12979_023_00405_0 crossref_primary_10_1016_j_foodres_2015_06_032 crossref_primary_10_1016_j_jneuroim_2023_578144 crossref_primary_10_1016_j_neuroscience_2024_10_014 crossref_primary_10_1155_2014_635784 crossref_primary_10_1186_s12979_023_00394_0 crossref_primary_10_1007_s10571_021_01063_w crossref_primary_10_1097_MD_0000000000036722 crossref_primary_10_1016_j_dci_2020_103884 crossref_primary_10_1016_j_phymed_2024_155349 crossref_primary_10_1080_14786419_2023_2208257 crossref_primary_10_4103_1673_5374_392854 crossref_primary_10_1016_j_gendis_2020_02_004 crossref_primary_10_1080_15376516_2022_2156006 crossref_primary_10_3390_md21120629 crossref_primary_10_1016_j_jep_2021_114183 crossref_primary_10_1016_j_intimp_2014_02_010 crossref_primary_10_1111_sji_13215 crossref_primary_10_3389_fimmu_2024_1474466 crossref_primary_10_1021_acsami_1c16126 crossref_primary_10_1007_s00210_024_03493_x crossref_primary_10_1002_fsn3_1297 crossref_primary_10_1002_mnfr_201300764 crossref_primary_10_1155_2023_9923111 crossref_primary_10_3390_ijms23147881 crossref_primary_10_1007_s00784_023_05139_3 crossref_primary_10_1039_D3TB01235B crossref_primary_10_3390_nu14204240 crossref_primary_10_1007_s12013_024_01410_w crossref_primary_10_1080_15384047_2023_2284857 crossref_primary_10_1016_j_jep_2024_118657 crossref_primary_10_1155_2022_8723119 crossref_primary_10_3390_app14135434 crossref_primary_10_1016_j_compbiomed_2024_109203 crossref_primary_10_1038_s41419_024_06559_z crossref_primary_10_1097_MD_0000000000035973 crossref_primary_10_1016_j_jid_2024_07_016 crossref_primary_10_7856_kjcls_2021_32_2_269 crossref_primary_10_1093_asjof_ojae008 crossref_primary_10_4274_qrheumatol_galenos_2024_96967 crossref_primary_10_1080_03008207_2022_2109468 crossref_primary_10_1096_fj_202201839R crossref_primary_10_3389_ti_2024_13227 crossref_primary_10_1038_s41598_025_90396_3 crossref_primary_10_1016_j_colsurfb_2024_114087 crossref_primary_10_3390_antib8010005 crossref_primary_10_1021_acsomega_3c06805 crossref_primary_10_3389_fmicb_2022_1089729 crossref_primary_10_1016_j_archoralbio_2024_106113 crossref_primary_10_52361_fsbh_2022_2_e9 crossref_primary_10_1016_j_bbih_2022_100536 crossref_primary_10_1080_10799893_2020_1726951 crossref_primary_10_3389_fendo_2023_1109296 crossref_primary_10_1007_s10735_025_10379_6 crossref_primary_10_1021_acs_jproteome_0c00229 crossref_primary_10_1097_MAO_0000000000004372 crossref_primary_10_3390_biomedicines10051025 crossref_primary_10_3390_ijms25031849 crossref_primary_10_1371_journal_pone_0193306 crossref_primary_10_1007_s10787_022_01092_x crossref_primary_10_1016_j_envpol_2018_09_047 crossref_primary_10_3390_ani12162125 crossref_primary_10_4049_jimmunol_2200053 crossref_primary_10_1016_j_bpsgos_2021_06_009 crossref_primary_10_1016_j_fsi_2023_109251 crossref_primary_10_1155_2015_916234 crossref_primary_10_3390_ijms22179208 crossref_primary_10_1016_j_jep_2020_112971 crossref_primary_10_3390_ijms22126272 crossref_primary_10_1186_s13102_021_00375_0 crossref_primary_10_1016_j_aninu_2021_11_005 crossref_primary_10_1016_j_nut_2021_111240 crossref_primary_10_1016_j_ijbiomac_2019_08_171 crossref_primary_10_1016_j_obmed_2020_100221 crossref_primary_10_3390_molecules28134991 crossref_primary_10_3390_molecules21101321 crossref_primary_10_1159_000448077 crossref_primary_10_1007_s13534_024_00366_3 crossref_primary_10_3390_medicina59020393 crossref_primary_10_1007_s00592_021_01759_x crossref_primary_10_1016_j_heliyon_2025_e43000 crossref_primary_10_1016_j_yexcr_2015_10_030 crossref_primary_10_3389_fmed_2024_1388665 crossref_primary_10_3390_pharmaceutics16010040 crossref_primary_10_1016_j_micpath_2017_11_037 crossref_primary_10_1016_j_jdermsci_2015_06_016 crossref_primary_10_3390_pharmaceutics15051370 crossref_primary_10_3389_fcimb_2023_1231541 crossref_primary_10_3892_mmr_2017_7405 crossref_primary_10_1111_bph_13619 crossref_primary_10_3390_ijms22147626 crossref_primary_10_2147_DDDT_S468119 crossref_primary_10_2174_1871529X18666180611094928 crossref_primary_10_3390_nu14153046 crossref_primary_10_2174_1386207324666210319122650 crossref_primary_10_1002_cbdv_201800269 crossref_primary_10_1016_j_clinbiochem_2013_09_011 crossref_primary_10_17352_2455_8605_000001 crossref_primary_10_1016_j_ejphar_2025_177505 crossref_primary_10_3390_microorganisms9051070 crossref_primary_10_3390_antiox11091752 crossref_primary_10_1007_s10753_020_01312_y crossref_primary_10_1016_j_intimp_2020_106803 crossref_primary_10_3892_mmr_2022_12820 crossref_primary_10_1186_1746_6148_9_170 crossref_primary_10_1080_01480545_2018_1509987 crossref_primary_10_12688_f1000research_110660_2 crossref_primary_10_12688_f1000research_110660_1 crossref_primary_10_3390_ijms252111386 crossref_primary_10_1007_s13770_023_00525_0 crossref_primary_10_1021_acschemneuro_3c00180 crossref_primary_10_1134_S0006297922090073 crossref_primary_10_3390_jcm13113098 crossref_primary_10_1016_j_heliyon_2024_e28029 crossref_primary_10_1016_j_rmr_2023_11_003 crossref_primary_10_3748_wjg_v27_i22_2944 crossref_primary_10_3897_pharmacia_71_e122410 crossref_primary_10_1007_s11051_014_2554_4 crossref_primary_10_3390_md20110667 crossref_primary_10_1007_s12035_022_02725_6 crossref_primary_10_1016_j_jormas_2023_101472 crossref_primary_10_3390_biom10111539 crossref_primary_10_3389_fimmu_2022_1044249 crossref_primary_10_1080_08916934_2021_1894417 crossref_primary_10_1002_lipd_12368 crossref_primary_10_1016_j_clnesp_2024_02_006 crossref_primary_10_1128_jvi_01401_22 crossref_primary_10_4103_jcsr_jcsr_67_23 crossref_primary_10_1016_j_ijbiomac_2024_138602 crossref_primary_10_1155_2021_4579850 crossref_primary_10_36899_JAPS_2022_5_0529 crossref_primary_10_1007_s10787_020_00687_6 crossref_primary_10_1007_s40291_015_0130_y crossref_primary_10_3390_v14010164 crossref_primary_10_1002_cbdv_202301916 crossref_primary_10_1016_j_cyto_2022_155955 crossref_primary_10_1016_j_exer_2020_108003 crossref_primary_10_33988_auvfd_1383903 crossref_primary_10_1016_j_snb_2024_135694 crossref_primary_10_1038_s41598_021_84748_y crossref_primary_10_1016_j_cyto_2020_155340 crossref_primary_10_1042_CS20160927 crossref_primary_10_1371_journal_pone_0194207 crossref_primary_10_17116_Cardiobulletin20231803123 crossref_primary_10_1093_ofid_ofaa407 crossref_primary_10_3389_fphar_2019_01509 crossref_primary_10_1016_j_biocel_2019_02_001 crossref_primary_10_3390_molecules26082106 crossref_primary_10_1186_s12920_021_00953_8 crossref_primary_10_3233_JAD_200658 crossref_primary_10_3390_ph15070771 crossref_primary_10_1007_s00394_022_03013_8 crossref_primary_10_1016_j_jep_2023_116824 crossref_primary_10_3389_fsurg_2015_00043 crossref_primary_10_1017_dmp_2023_178 crossref_primary_10_1186_s12859_019_3304_5 crossref_primary_10_1016_j_jep_2019_02_015 crossref_primary_10_1002_jbm_b_35303 crossref_primary_10_3390_nu16213658 crossref_primary_10_1155_2022_6944792 crossref_primary_10_3390_antiox11061192 crossref_primary_10_3390_antiox12122084 crossref_primary_10_3390_molecules26247642 crossref_primary_10_3892_ijmm_2023_5336 crossref_primary_10_3389_fonc_2022_1101289 crossref_primary_10_1007_s00383_022_05221_z crossref_primary_10_3390_molecules24224100 crossref_primary_10_1007_s11696_024_03614_z crossref_primary_10_1007_s00044_024_03332_x crossref_primary_10_3389_fimmu_2023_1222308 crossref_primary_10_4103_0972_9062_364759 crossref_primary_10_1016_j_intimp_2021_107377 crossref_primary_10_3389_fonc_2025_1514009 crossref_primary_10_3390_ijms24097814 crossref_primary_10_3390_ani12020146 crossref_primary_10_3390_ijerph19094984 crossref_primary_10_3390_biomedicines13020499 crossref_primary_10_1089_jmf_2018_4180 crossref_primary_10_3390_ijms20236008 crossref_primary_10_1080_08923973_2021_1988101 crossref_primary_10_3390_colloids8030039 crossref_primary_10_12998_wjcc_v11_i2_342 crossref_primary_10_1590_fst_96821 crossref_primary_10_1016_j_biopha_2022_112723 crossref_primary_10_1039_D0MD00208A crossref_primary_10_1155_2018_4923062 crossref_primary_10_1016_j_drudis_2023_103846 crossref_primary_10_1016_j_tice_2022_101964 crossref_primary_10_1155_2014_169082 crossref_primary_10_1042_BSR20181052 crossref_primary_10_1021_acs_biomac_0c01329 crossref_primary_10_1155_2024_2550367 crossref_primary_10_3389_fmicb_2018_01684 crossref_primary_10_22358_jafs_134117_2021 crossref_primary_10_1016_j_jphs_2024_08_003 crossref_primary_10_1016_j_taap_2021_115677 crossref_primary_10_1002_slct_202400621 crossref_primary_10_1016_j_cca_2020_07_049 crossref_primary_10_4103_ijmr_IJMR_542_15 crossref_primary_10_1371_journal_pone_0159151 crossref_primary_10_1007_s00109_019_01778_w crossref_primary_10_1016_j_fitote_2024_105939 crossref_primary_10_3389_fphar_2024_1334474 crossref_primary_10_3390_ijms251910642 crossref_primary_10_1186_s40001_024_02156_0 crossref_primary_10_20900_agmr20200025 crossref_primary_10_3839_jabc_2025_001 crossref_primary_10_1016_j_biopha_2021_112345 crossref_primary_10_1177_15353702221126562 crossref_primary_10_3892_etm_2019_7371 crossref_primary_10_1007_s10787_020_00685_8 crossref_primary_10_1002_ptr_7359 crossref_primary_10_1016_j_nefro_2023_11_005 crossref_primary_10_3390_ijms17111869 crossref_primary_10_1016_j_apsadv_2023_100527 crossref_primary_10_1111_1440_1681_12242 crossref_primary_10_3390_biology13110896 crossref_primary_10_3389_fphar_2023_1207999 crossref_primary_10_1111_jcmm_15309 crossref_primary_10_3389_fimmu_2022_1001623 crossref_primary_10_1002_cac2_12295 crossref_primary_10_1016_j_disamonth_2021_101300 crossref_primary_10_1371_journal_pone_0287147 crossref_primary_10_3390_cancers12061600 crossref_primary_10_1111_iej_13987 crossref_primary_10_1007_s11418_022_01665_8 crossref_primary_10_1017_S0007114516003846 crossref_primary_10_3390_biom13071144 crossref_primary_10_3390_ijms25094879 crossref_primary_10_1007_s00011_014_0760_2 crossref_primary_10_1007_s12035_024_04401_3 crossref_primary_10_4049_jimmunol_2101103 crossref_primary_10_3389_fphar_2020_620038 crossref_primary_10_18311_jnr_2024_30528 crossref_primary_10_3746_jkfn_2023_52_11_1101 crossref_primary_10_1016_j_intimp_2023_110503 crossref_primary_10_1155_2022_7313864 crossref_primary_10_1016_j_physbeh_2022_113776 crossref_primary_10_1016_j_jff_2022_105044 crossref_primary_10_1016_j_aquaculture_2020_735573 crossref_primary_10_3390_foods12091772 crossref_primary_10_3390_ijms16010535 crossref_primary_10_3390_ijms242417550 crossref_primary_10_1016_j_biopha_2021_111670 crossref_primary_10_1093_toxres_tfac005 crossref_primary_10_3390_v14061210 crossref_primary_10_1016_j_tice_2022_101998 crossref_primary_10_1097_MD_0000000000037390 crossref_primary_10_1155_2020_3849847 crossref_primary_10_2174_1381612826666200413082353 crossref_primary_10_1097_JBR_0000000000000118 crossref_primary_10_1128_mBio_00266_19 crossref_primary_10_1016_j_vetimm_2021_110284 crossref_primary_10_3389_fimmu_2021_780641 crossref_primary_10_3389_fphar_2021_583279 crossref_primary_10_1080_17568919_2024_2437981 crossref_primary_10_1186_s12872_022_02702_w crossref_primary_10_3748_wjg_v29_i16_2397 crossref_primary_10_1186_s12967_025_06122_0 crossref_primary_10_3389_fimmu_2021_688861 crossref_primary_10_1016_j_bbi_2020_07_006 crossref_primary_10_3389_fcell_2024_1440914 crossref_primary_10_1021_acsomega_3c06450 crossref_primary_10_1016_j_jare_2025_01_033 crossref_primary_10_1155_2021_8865601 crossref_primary_10_3390_cells10071824 crossref_primary_10_1016_j_arabjc_2022_104269 crossref_primary_10_1007_s10787_021_00827_6 crossref_primary_10_1016_j_scitotenv_2022_161092 crossref_primary_10_3390_ijms24076142 crossref_primary_10_1080_21688370_2022_2090792 crossref_primary_10_1099_jmm_0_001374 crossref_primary_10_52711_0974_360X_2022_00375 crossref_primary_10_3390_biom11101464 crossref_primary_10_3390_ijms25052948 crossref_primary_10_2174_1386207324666210827112233 crossref_primary_10_1002_adfm_202214937 crossref_primary_10_1016_j_envres_2023_117249 crossref_primary_10_1093_jas_skad133 crossref_primary_10_1093_jas_skab199 crossref_primary_10_1080_15376516_2023_2291123 crossref_primary_10_3390_cells9122658 crossref_primary_10_3390_ijerph182212162 crossref_primary_10_1016_j_jep_2019_01_028 crossref_primary_10_3390_cancers13071563 crossref_primary_10_1186_s12943_024_02107_7 crossref_primary_10_1016_j_jep_2023_117505 crossref_primary_10_1016_j_jpba_2024_116219 crossref_primary_10_31083_j_jin2305101 crossref_primary_10_1016_j_yjmcc_2022_06_007 crossref_primary_10_1080_1354750X_2017_1419284 crossref_primary_10_1177_1753425915613425 crossref_primary_10_1371_journal_pone_0138326 crossref_primary_10_1007_s10753_016_0409_0 crossref_primary_10_1111_aji_13624 crossref_primary_10_1139_cjpp_2022_0451 crossref_primary_10_3389_fphar_2024_1491223 crossref_primary_10_1002_eer3_20 crossref_primary_10_3389_fcell_2021_617134 crossref_primary_10_3390_biomedicines11112922 crossref_primary_10_1371_journal_pone_0109901 crossref_primary_10_3390_ph15091063 crossref_primary_10_1016_j_toxicon_2018_06_063 crossref_primary_10_1155_2021_8812090 crossref_primary_10_3390_ani15020163 crossref_primary_10_1002_ptr_7541 crossref_primary_10_3390_ijms23052508 crossref_primary_10_1155_2021_2809004 crossref_primary_10_1016_j_etap_2023_104298 crossref_primary_10_1039_D3FO01688A crossref_primary_10_1016_j_envint_2024_109025 crossref_primary_10_1039_C8BM01224E crossref_primary_10_3724_SP_J_1329_2022_02008 crossref_primary_10_1016_j_fbio_2024_105038 crossref_primary_10_1038_s41536_021_00179_3 crossref_primary_10_3389_fimmu_2024_1468469 crossref_primary_10_3390_molecules21010043 crossref_primary_10_1016_j_toxicon_2016_08_018 crossref_primary_10_1002_med_21753 crossref_primary_10_1007_s12011_024_04486_w crossref_primary_10_1016_j_bbamcr_2014_11_022 crossref_primary_10_1038_s44321_024_00035_z crossref_primary_10_3390_md20120789 crossref_primary_10_1016_j_jvoice_2024_12_015 crossref_primary_10_1007_s11064_022_03776_w crossref_primary_10_3389_fimmu_2022_835997 crossref_primary_10_3390_ph16101415 crossref_primary_10_1080_15368378_2023_2265935 crossref_primary_10_3892_etm_2024_12567 crossref_primary_10_1371_journal_pone_0207346 crossref_primary_10_3389_fimmu_2023_1228928 crossref_primary_10_3389_fonc_2025_1512460 crossref_primary_10_1074_jbc_RA118_006022 crossref_primary_10_1097_HP_0000000000001532 crossref_primary_10_3390_ijms21093072 crossref_primary_10_1016_j_jad_2022_11_063 crossref_primary_10_1007_s00011_022_01672_1 crossref_primary_10_1007_s44187_024_00230_4 crossref_primary_10_1016_j_ejmech_2022_114956 crossref_primary_10_15616_BSL_2020_26_1_51 crossref_primary_10_1016_j_pbiomolbio_2024_07_003 crossref_primary_10_1016_j_cyto_2016_09_013 crossref_primary_10_2174_0113862073261351231005111817 crossref_primary_10_7759_cureus_56223 crossref_primary_10_1038_s41366_022_01111_5 crossref_primary_10_1038_s42003_021_02739_1 crossref_primary_10_1590_S0102_865020160020000007 crossref_primary_10_3390_molecules26082368 crossref_primary_10_3390_foods12030450 crossref_primary_10_3390_ijms24065383 crossref_primary_10_1371_journal_pone_0141933 crossref_primary_10_1186_s12974_021_02332_7 crossref_primary_10_1186_s13287_019_1247_4 crossref_primary_10_1080_01480545_2024_2330014 crossref_primary_10_1016_j_molimm_2019_08_013 crossref_primary_10_1002_hep4_1438 crossref_primary_10_1093_abbs_gmv092 crossref_primary_10_22159_ijap_2023_v15s1_01 crossref_primary_10_1016_j_jri_2021_103289 crossref_primary_10_1016_j_jaip_2019_01_036 crossref_primary_10_3389_fphar_2024_1366695 crossref_primary_10_1371_journal_pone_0136116 crossref_primary_10_1186_s12967_019_1965_5 crossref_primary_10_3389_fimmu_2018_00754 crossref_primary_10_1016_j_joim_2020_06_001 crossref_primary_10_1177_08850666211044100 crossref_primary_10_1615_CritRevEukaryotGeneExpr_2022044300 crossref_primary_10_1007_s11033_022_08086_6 crossref_primary_10_3390_jcm13133693 crossref_primary_10_1007_s13205_023_03770_1 crossref_primary_10_3389_fnut_2022_963271 crossref_primary_10_1186_s12951_024_02996_2 crossref_primary_10_1016_j_clim_2021_108875 crossref_primary_10_1016_j_heliyon_2024_e27164 crossref_primary_10_1080_09540105_2024_2351360 crossref_primary_10_1097_MD_0000000000038785 crossref_primary_10_1161_HYPERTENSIONAHA_122_19464 crossref_primary_10_1186_s42269_021_00586_y crossref_primary_10_1021_acs_jafc_2c00102 crossref_primary_10_1016_j_bcp_2023_115876 crossref_primary_10_1016_j_impact_2021_100334 crossref_primary_10_1016_j_bbadis_2015_10_017 crossref_primary_10_3390_pharmaceutics13111930 crossref_primary_10_1016_j_taap_2021_115827 crossref_primary_10_1186_s12959_025_00700_4 crossref_primary_10_1016_j_jep_2015_03_032 crossref_primary_10_3390_biom11020329 crossref_primary_10_1155_2022_6584631 crossref_primary_10_1177_22143602251315376 crossref_primary_10_1016_j_cej_2023_144345 crossref_primary_10_1128_spectrum_03655_22 crossref_primary_10_1002_adhm_202302063 crossref_primary_10_1016_j_marenvres_2024_106596 crossref_primary_10_3390_ijms251910474 crossref_primary_10_1155_2023_4086631 crossref_primary_10_2174_1570180820666230828151523 crossref_primary_10_1093_rb_rbad110 crossref_primary_10_1016_j_ijbiomac_2021_03_082 crossref_primary_10_3390_immuno1040025 crossref_primary_10_1080_15569527_2022_2081702 crossref_primary_10_1186_s43088_022_00273_5 crossref_primary_10_1016_j_scitotenv_2024_174737 crossref_primary_10_1371_journal_pcbi_1010626 crossref_primary_10_1242_jeb_200055 crossref_primary_10_1016_j_carrev_2021_03_023 crossref_primary_10_1016_j_repbio_2024_100855 crossref_primary_10_3390_antiox12081636 crossref_primary_10_1021_acsomega_4c01025 crossref_primary_10_3389_fphar_2021_644129 crossref_primary_10_3390_app112110092 crossref_primary_10_1155_2022_8227314 crossref_primary_10_1016_j_fitote_2021_104949 crossref_primary_10_7717_peerj_13330 crossref_primary_10_3389_fphys_2016_00029 crossref_primary_10_1093_labmed_lmad026 crossref_primary_10_3390_nu13103376 crossref_primary_10_1080_13102818_2019_1674690 crossref_primary_10_1016_j_mce_2024_112420 crossref_primary_10_3892_etm_2018_6094 crossref_primary_10_1016_j_tox_2018_07_001 crossref_primary_10_3390_jcm8111981 crossref_primary_10_1155_2017_7359760 crossref_primary_10_1016_j_cej_2020_128123 crossref_primary_10_18097_pbmc20247003168 crossref_primary_10_3892_mmr_2017_7154 crossref_primary_10_1016_j_bbih_2023_100645 crossref_primary_10_1038_s41598_023_47303_5 crossref_primary_10_1093_tas_txae147 crossref_primary_10_1007_s11064_024_04270_1 crossref_primary_10_1007_s10753_022_01776_0 crossref_primary_10_1097_MS9_0000000000000466 crossref_primary_10_1016_j_biopha_2021_111816 crossref_primary_10_1016_j_biopha_2022_113186 crossref_primary_10_1080_14712598_2025_2471093 crossref_primary_10_3892_br_2022_1546 crossref_primary_10_1111_pan_14643 crossref_primary_10_1016_j_intimp_2025_114153 crossref_primary_10_1007_s10067_015_3115_7 crossref_primary_10_14814_phy2_13676 crossref_primary_10_1016_j_jchemneu_2021_101939 crossref_primary_10_1016_j_ctcp_2020_101291 crossref_primary_10_3390_md13106038 crossref_primary_10_1016_j_joen_2020_06_009 crossref_primary_10_1155_2019_3746326 crossref_primary_10_17343_sdutfd_1114352 crossref_primary_10_2147_JIR_S408929 crossref_primary_10_1007_s10787_025_01644_x crossref_primary_10_1186_1471_2334_14_416 crossref_primary_10_3390_ijms24021358 crossref_primary_10_3390_ijms242015186 crossref_primary_10_1007_s10753_020_01307_9 crossref_primary_10_1016_j_cclet_2024_110561 crossref_primary_10_1111_fcp_12627 crossref_primary_10_1016_j_intimp_2023_110004 crossref_primary_10_1016_j_cellsig_2022_110409 crossref_primary_10_1016_j_hsr_2021_100011 crossref_primary_10_1016_j_biopha_2022_114045 crossref_primary_10_1007_s00210_023_02833_7 crossref_primary_10_3177_jnsv_70_481 crossref_primary_10_1111_1756_185X_15147 crossref_primary_10_1016_j_intimp_2017_01_026 crossref_primary_10_1016_j_biopha_2017_07_014 crossref_primary_10_1002_ejp_1630 crossref_primary_10_1515_med_2022_0619 crossref_primary_10_18008_1816_5095_2018_4_463_469 crossref_primary_10_1016_j_tice_2024_102422 crossref_primary_10_3390_molecules24244531 crossref_primary_10_3390_molecules30020266 crossref_primary_10_1002_cbf_3370 crossref_primary_10_3390_ijms23137227 crossref_primary_10_3390_ijms23137226 crossref_primary_10_3390_antibiotics11111477 crossref_primary_10_3892_ijmm_2018_3786 crossref_primary_10_1186_1477_5956_12_30 crossref_primary_10_1016_j_intimp_2018_03_025 crossref_primary_10_1016_j_jep_2018_04_017 crossref_primary_10_1016_j_nantod_2023_102108 crossref_primary_10_3103_S0096392514040105 crossref_primary_10_1111_jdi_12542 crossref_primary_10_3390_cancers14133039 crossref_primary_10_1016_j_jff_2023_105633 crossref_primary_10_1002_ibra_12089 crossref_primary_10_3390_ijms20194756 crossref_primary_10_1016_j_pharmthera_2020_107752 crossref_primary_10_1016_j_rvsc_2019_09_010 crossref_primary_10_1128_JVI_02098_15 crossref_primary_10_2174_1871530322666220704101310 crossref_primary_10_3390_ijms232113016 crossref_primary_10_1111_aji_13632 crossref_primary_10_1016_j_lfs_2023_121996 crossref_primary_10_1080_20008198_2021_1987655 crossref_primary_10_3390_molecules24244502 crossref_primary_10_3390_plants11192519 crossref_primary_10_1007_s00018_020_03470_6 crossref_primary_10_1016_j_envres_2021_111242 crossref_primary_10_1016_j_jksus_2020_101314 crossref_primary_10_2217_nnm_2017_0126 crossref_primary_10_3390_cosmetics8020042 crossref_primary_10_1371_journal_pone_0181822 crossref_primary_10_1016_j_cytogfr_2024_12_003 crossref_primary_10_1097_SAP_0000000000003980 crossref_primary_10_1007_s11064_021_03501_z crossref_primary_10_1016_j_exger_2023_112132 crossref_primary_10_1016_j_cpccr_2024_100320 crossref_primary_10_3390_v13112209 crossref_primary_10_1080_21691401_2020_1716781 crossref_primary_10_1016_j_jdermsci_2023_10_003 crossref_primary_10_1016_j_cpcardiol_2023_102081 crossref_primary_10_32607_actanaturae_27317 crossref_primary_10_1002_pmic_202300023 crossref_primary_10_1016_j_curtheres_2023_100720 crossref_primary_10_1016_j_chemosphere_2023_139300 crossref_primary_10_1017_S0022149X21000341 crossref_primary_10_1111_omi_12361 crossref_primary_10_1586_17474086_2015_1049593 crossref_primary_10_1007_s10753_024_02095_2 crossref_primary_10_1002_jsfa_7159 crossref_primary_10_1080_03069885_2022_2039899 crossref_primary_10_1016_j_jpain_2022_04_005 crossref_primary_10_2174_0113852728301440240620093751 crossref_primary_10_1016_j_pbb_2015_08_007 crossref_primary_10_1177_0885328217744080 crossref_primary_10_1186_s12931_022_02214_3 crossref_primary_10_1039_D2BM01113A crossref_primary_10_1016_j_molimm_2019_09_009 crossref_primary_10_1128_spectrum_01504_21 crossref_primary_10_3390_pharmaceutics15041279 crossref_primary_10_1016_j_nefroe_2023_11_003 crossref_primary_10_1055_a_1471_8947 crossref_primary_10_3390_jcm13164919 crossref_primary_10_4110_in_2024_24_e27 crossref_primary_10_1002_advs_202309709 crossref_primary_10_1039_D2FO02775E crossref_primary_10_1016_j_biopsych_2021_06_007 crossref_primary_10_1016_j_intimp_2025_114166 crossref_primary_10_1016_j_prp_2022_154085 crossref_primary_10_1016_j_tox_2022_153410 crossref_primary_10_3923_ijp_2023_623_631 crossref_primary_10_1038_s41598_025_86876_1 crossref_primary_10_1177_26348535241277625 crossref_primary_10_12688_f1000research_112921_2 crossref_primary_10_12688_f1000research_112921_1 crossref_primary_10_3390_molecules25030598 crossref_primary_10_3389_fphar_2021_631102 crossref_primary_10_1016_j_aquaculture_2024_741600 crossref_primary_10_1002_ptr_6944 crossref_primary_10_1016_j_celrep_2022_110988 crossref_primary_10_1074_jbc_M116_752469 crossref_primary_10_1016_j_ecoenv_2024_117385 crossref_primary_10_2147_JIR_S297348 crossref_primary_10_3390_ani11123539 crossref_primary_10_1038_s41598_018_20220_8 crossref_primary_10_3389_fvets_2023_1157935 crossref_primary_10_1016_j_ijpharm_2021_120712 crossref_primary_10_1590_fst_55720 crossref_primary_10_1016_j_ijdevneu_2015_05_003 crossref_primary_10_1016_j_intimp_2021_107801 crossref_primary_10_3389_fitd_2022_969307 crossref_primary_10_2174_2772270816666220119122259 crossref_primary_10_3389_fphar_2022_863646 crossref_primary_10_1016_j_cyto_2024_156515 |
| Cites_doi | 10.1073/pnas.95.2.570 10.1038/cr.2010.178 10.1007/s00395-008-0749-5 10.1016/0092-8674(90)90815-V 10.1111/j.1553-2712.2000.tb02077.x 10.1126/science.288.5475.2351 10.1385/IR:27:2-3:529 10.1016/S0092-8674(00)80984-8 10.1016/0092-8674(88)90486-2 10.1182/blood-2002-07-2303 10.1002/(SICI)1098-2744(200002)27:2<97::AID-MC5>3.0.CO;2-V 10.1016/j.placenta.2008.10.012 10.1016/S0196-9781(98)00087-4 10.1136/heart.85.3.342 10.1016/j.it.2004.03.008 10.1016/S1074-7613(00)80252-6 10.1016/S0140-6736(89)92394-5 10.1016/j.intimp.2008.05.004 10.1074/jbc.273.5.2926 10.1126/science.3754653 10.1002/path.2287 10.1016/S0092-8674(00)80406-7 10.1152/ajplung.00109.2006 10.1038/sj.bjc.6605530 10.1016/j.pharmthera.2007.10.001 10.1038/nri1312 10.1016/0092-8674(95)90192-2 10.1189/jlb.1202618 10.1186/cc1825 10.1016/j.molimm.2007.05.017 10.1001/archsurg.133.5.558 10.1086/302517 10.1038/sj.bjp.0701815 10.1016/j.ejca.2006.01.012 10.1158/0008-5472.CAN-05-0957 10.1038/sj.onc.1209936 10.1074/jbc.M008353200 10.1038/sj.cdd.4401189 10.1038/nri910 10.1177/026765910101600110 10.1007/3-540-26511-2_7 10.1016/S1074-7613(00)80194-6 10.1111/j.1538-7836.2006.02035.x 10.1006/bcmd.1998.0187 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H 10.1042/BSR20100136 10.1016/j.cytogfr.2004.03.011 10.1016/S1359-6101(01)00020-X 10.1016/0888-7543(92)90226-I 10.1074/jbc.M212662200 10.1126/science.4048937 10.1074/jbc.M310678200 10.1016/0092-8674(90)90816-W 10.1111/j.1742-4658.2011.08017.x 10.1016/j.bcp.2006.08.007 10.1038/385729a0 10.1016/j.semcancer.2011.12.005 10.1128/MCB.25.6.2320-2330.2005 10.1038/nrd3030 10.1016/S1471-4892(01)00054-6 10.1016/j.bcp.2006.06.029 10.1067/msy.2000.101584 10.1172/JCI114111 10.1084/jem.175.2.323 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q 10.1385/IR:26:1-3:323 10.1016/S0962-8924(01)02064-5 10.1016/j.prp.2010.12.003 10.1016/S0002-9610(01)00822-4 10.1073/pnas.1015282107 10.1038/nri1629 10.1038/ni0503-404 10.1038/nature01576 10.1074/jbc.M109.037341 10.1152/ajplung.00378.2002 10.1111/j.1432-1033.1991.tb16337.x 10.1074/jbc.274.41.28978 10.1016/j.bpa.2003.12.002 10.1016/j.it.2008.07.003 10.1152/ajprenal.00066.2008 10.1182/blood-2006-05-020875 10.1016/S0021-9258(18)71533-0 10.1128/MCB.17.7.4015 10.1074/jbc.M009147200 10.1016/S0021-9258(18)37865-7 10.4049/jimmunol.175.2.1197 10.4049/jimmunol.143.12.4034 10.1152/physrev.2001.81.2.807 10.1007/s00134-002-1617-7 10.1016/j.bbapap.2005.08.017 10.1016/S0165-6147(97)01097-3 10.1152/physrev.1999.79.1.143 10.1177/154405910708600902 10.1074/jbc.271.9.4961 10.1074/jbc.270.22.13303 10.1042/bj2980249 10.1016/S0022-3565(24)29632-4 10.1200/JCO.1997.15.2.499 10.1146/annurev.cb.10.110194.002201 10.1007/978-1-59259-963-9_72 10.1002/j.1460-2075.1995.tb00245.x 10.1074/jbc.271.35.21151 |
| ContentType | Journal Article |
| Copyright | Springer Basel 2013 |
| Copyright_xml | – notice: Springer Basel 2013 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 |
| DOI | 10.1007/s00011-013-0633-0 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1420-908X |
| EndPage | 651 |
| ExternalDocumentID | 23685857 10_1007_s00011_013_0633_0 |
| Genre | Journal Article Review |
| GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 2.D 203 28- 29I 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3O- 3SX 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67N 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACZOJ ADBBV ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFGCZ AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EN4 EPAXT ESBYG FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ IHE IJ- IKXTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P PF0 PKN PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZN T13 T16 TEORI TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK6 WK8 X7M Y6R YLTOR Z45 Z7U Z7W Z82 Z87 Z8O Z8Q Z8V Z91 ZGI ZMTXR ZOVNA ZXP ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY 7X8 7T5 H94 |
| ID | FETCH-LOGICAL-c377t-a66b300dbf9bc4bdbd8fc2a9f8121f991b2c8cba9c9d3c1d9ed1dcb70b4e47e73 |
| IEDL.DBID | U2A |
| ISSN | 1023-3830 1420-908X |
| IngestDate | Fri Jul 11 03:41:27 EDT 2025 Tue Aug 05 11:26:00 EDT 2025 Mon Jul 21 06:04:58 EDT 2025 Tue Jul 01 05:03:37 EDT 2025 Thu Apr 24 22:58:14 EDT 2025 Fri Feb 21 02:36:40 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | TNFR Inflammation TNF-α Apoptosis Cancer |
| Language | English |
| License | http://www.springer.com/tdm |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c377t-a66b300dbf9bc4bdbd8fc2a9f8121f991b2c8cba9c9d3c1d9ed1dcb70b4e47e73 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| PMID | 23685857 |
| PQID | 1367879950 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_1412504348 proquest_miscellaneous_1367879950 pubmed_primary_23685857 crossref_citationtrail_10_1007_s00011_013_0633_0 crossref_primary_10_1007_s00011_013_0633_0 springer_journals_10_1007_s00011_013_0633_0 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20130700 2013-7-00 2013-Jul 20130701 |
| PublicationDateYYYYMMDD | 2013-07-01 |
| PublicationDate_xml | – month: 7 year: 2013 text: 20130700 |
| PublicationDecade | 2010 |
| PublicationPlace | Basel |
| PublicationPlace_xml | – name: Basel – name: Switzerland |
| PublicationSubtitle | Official Journal of: The International Association of Inflammation Societies + The European Histamine Research Society |
| PublicationTitle | Inflammation research |
| PublicationTitleAbbrev | Inflamm. Res |
| PublicationTitleAlternate | Inflamm Res |
| PublicationYear | 2013 |
| Publisher | SP Birkhäuser Verlag Basel |
| Publisher_xml | – name: SP Birkhäuser Verlag Basel |
| References | Black, Rauch, Kozlosky, Peschon, Slack, Wolfson, Castner (CR13) 1997; 6618 Cone (CR67) 2001; 6 Vallance, Chan (CR70) 2001; 3 Gaiotti, Chung, Iglesias, Nees, Baker, Evans, Woodworth (CR101) 2000; 2 Camussi, Albano, Tetta, Bussolino (CR20) 1991; 1 Kulbe, Hagemann, Szlosarek, Balkwill, Wilson (CR110) 2005; 22 De Cesaris, Starace, Starace, Filippini, Stefanini, Ziparo (CR106) 1999; 41 Zandi, Rothwarf, Delhase, Hayakawa, Karin (CR46) 1997; 2 Sun (CR61) 2008; 10 Yoshida, Ono, Shono, Izumi, Ishibashi, Suzuki, Kuwano (CR104) 1997; 7 Beutler, Bazzoni (CR4) 1998; 10 Wu, Boyer, Whitaker, Berchuck, Wiener, Weinberg, Bast (CR102) 1993; 8 Kischkel, Hellbardt, Behrmann, Germer, Pawlita, Krammer, Peter (CR57) 1995; 22 Hajeer, Hutchinson (CR32) 2000; 3 Schall, Lewis, Koller, Lee, Rice, Wong, Gatanaga (CR26) 1990; 2 Campos, Souza, Calixto (CR81) 1998; 7 Szlosarek, Charles, Balkwill (CR98) 2006; 6 Muzio, Stockwell, Stennicke, Salvesen, Dixit (CR58) 1998; 5 Loetscher, Pan, Lahm, Gentz, Brockhaus, Tabuchi, Lesslauer (CR25) 1990; 2 Grell, Douni, Wajant, Lohden, Clauss, Maxeiner, Georgopoulos (CR35) 1995; 5 Balkwill, Mantovani (CR97) 2012; 1 Duda, Nagy, Männel, Eissner, Damjanovich (CR6) 2005 CR41 Zhou, Gengaro, Wang, Wang, Li, Faubel, Rivard (CR66) 2008; 4 Yoshida, Tsunawaki (CR91) 2008; 10 Aggarwal, Shishodia, Sandur, Pandey, Sethi (CR100) 2006; 11 Haider, Knofler (CR63) 2009; 2 Deleault, Skinner, Brooks (CR10) 2008; 1 Briscoe, Schoen, Rice, Bevilacqua, Ganz, Pober (CR85) 1991; 2 Li, Verma (CR42) 2002; 10 Ulfhammer, Larsson, Karlsson, Hrafnkelsdóttir, Bokarewa, Tarkowski, Jern (CR88) 2006; 8 Cairns, Panacek, Harken, Banerjee (CR19) 2000; 8 CR59 Naismith, Devine, Brandhuber, Sprang (CR5) 1995; 22 Zhang, Xu, Ekman, Wu, Wu, Alitalo, Min (CR65) 2003; 51 Tibbetts, Zheng, Lenardo (CR56) 2003; 5 Bradley (CR16) 2008; 2 Kaminska (CR53) 2005; 1–2 Widmann, Gibson, Jarpe, Johnson (CR50) 1999; 1 Tracey, Klareskog, Sasso, Salfeld, Tak (CR34) 2008; 2 Ksontini, MacKay, Moldawer (CR24) 1998; 5 Li, Fang, Gaynor (CR47) 2001; 6 Tracey, Vlassara, Cerami (CR17) 1989; 8647 Angelini, Hyun, Grigoryev, Garg, Gong, Singh, Passaniti (CR80) 2006; 6 Aderka, Engelmann, Maor, Brakebusch, Wallach (CR31) 1992; 2 Tabernero, Schneider, Potenza, Randriamboavonjy, Chasserot, Wolf, Mitolo-Chieppa (CR71) 2003; 2 Chan, Chun, Zheng, Siegel, Bui, Lenardo (CR37) 2000; 5475 Eissner, Kolch, Scheurich (CR14) 2004; 5 Li, Fan, Christie, Shah (CR93) 2005; 6 Riewald, Ruf (CR86) 2003; 2 Cheng, Chen (CR105) 2001; 17 Santee, Owen-Schaub (CR28) 1996; 35 Schindler, Monahan, Smith (CR54) 2007; 9 Faustman, Davis (CR64) 2010; 6 Dejardin (CR43) 2006; 9 Yamamoto, Verma, Prajapati, Kwak, Gaynor (CR49) 2003; 6940 Spriggs, Deutsch, Kufe (CR7) 1992; 56 Lambeth (CR90) 2004; 3 Lee, Kim, Sanford, Sullivan (CR22) 2003; 6 Devin, Cook, Lin, Rodriguez, Kelliher, Liu (CR45) 2000; 4 Rahman, Kefer, Bando, Niles, Malik (CR92) 1998; 3 Chinnaiyan, Tepper, Seldin, O’Rourke, Kischkel, Hellbardt, Krammer (CR55) 1996; 9 Zhou, Mountz, Kimberly (CR3) 2002; 1–3 Bonizzi, Karin (CR48) 2004; 6 Bubici, Papa, Dean, Franzoso (CR94) 2006; 51 Eder (CR40) 1997; 9 Denzlinger, Rapp, Hagmann, Keppler (CR76) 1985; 4723 Kumar, Blake, Emery (CR51) 2001; 3 Fuchs, Strehl, Dworzak, Himmler, Ambros (CR27) 1992; 1 Kyriakis, Avruch (CR52) 2001; 2 Warzocha, Salles, Bienvenu, Bastion, Dumontet, Renard, Neidhardt-Berard, Coiffier (CR111) 1997; 2 Wang, Al-Lamki, Zhang, Kirkiles-Smith, Gaeta, Thiru, Pober (CR33) 2003; 24 Sethi, Shanmugam, Ramachandran, Kumar, Tergaonkar (CR96) 2012; 1 CR73 Rauert, Wicovsky, Muller, Siegmund, Spindler, Waschke, Kneitz (CR62) 2010; 10 Morgan, Liu (CR89) 2011; 1 Kriegler, Perez, DeFay, Albert, Lu (CR11) 1988; 1 Mark, Trickler, Miller (CR75) 2001; 3 Pawlinski, Pedersen, Kehrle, Aird, Frank, Guha, Mackman (CR87) 2003; 10 Lin, Calvano, Lowry (CR18) 2000; 2 Hsu, Huang, Shu, Baichwal, Goeddel (CR39) 1996; 4 Grell, Wajant, Zimmermann, Scheurich (CR36) 1998; 2 Neumann, Gertzberg, Johnson (CR74) 2004; 2 Steinman (CR95) 2010; 48 Goldblum, Sun (CR79) 1990; 2 Baud, Karin (CR1) 2001; 9 Luettig, Decker, Lohmann-Matthes (CR12) 1989; 12 Wajant, Pfizenmaier, Scheurich (CR2) 2003; 1 Ledgerwood, Pober, Bradley (CR29) 1999; 9 Hagemann, Wilson, Kulbe, Li, Leinster, Charles, Klemm, Pukrop, Binder, Balkwill (CR109) 2005; 2 Balkwill (CR99) 2002; 2 Siebenlist, Brown, Claudio (CR44) 2005; 6 Sherwood, Toliver-Kinsky (CR68) 2004; 3 Wu, Zhou (CR108) 2010; 4 Sanders, Larson, Hunter, Gorman, Yang (CR72) 2001; 1 Smith, Marlin, Rothlein, Toman, Anderson (CR84) 1989; 6 Ruuls, Sedgwick (CR8) 1999; 2 Rees, Monkhouse, Cambridge, Moncada (CR69) 1998; 3 Hsu, Shu, Pan, Goeddel (CR38) 1996; 2 Naude, den Boer, Luiten, Eisel (CR60) 2011; 6 Mommsen, Barkhausen, Hildebrand, Zeckey, Krettek (CR83) 2011; 3 Jaiswal, LaRusso, Burgart, Gores (CR103) 2000; 1 Chappell, Hofmann-Kiefer, Jacob, Rehm, Briegel, Welsch, Conzen (CR78) 2009; 1 Sullivan (CR21) 2003; 2–3 Friedl, Till, Trentz, Ward (CR77) 1989; 1 Idriss, Naismith (CR9) 2000; 3 Eck, Sprang (CR15) 1989; 29 Chandrasekharan, Siemionow, Unsal, Yang, Poptic, Bohn, Ozer (CR82) 2007; 5 Ihnatko, Kubes (CR30) 2007; 3 Bussolino, Camussi, Baglioni (CR107) 1988; 24 Beutler, Krochin, Milsark, Luedke, Cerami (CR23) 1986; 4753 MD Tibbetts (633_CR56) 2003; 5 P Fuchs (633_CR27) 1992; 1 HP Friedl (633_CR77) 1989; 1 R Ihnatko (633_CR30) 2007; 3 XH Li (633_CR47) 2001; 6 633_CR41 Q Li (633_CR42) 2002; 10 LS Yoshida (633_CR91) 2008; 10 DB Sanders (633_CR72) 2001; 1 CW Smith (633_CR84) 1989; 6 DM Briscoe (633_CR85) 1991; 2 JH Naismith (633_CR5) 1995; 22 KJ Tracey (633_CR17) 1989; 8647 J Eder (633_CR40) 1997; 9 C Widmann (633_CR50) 1999; 1 DD Rees (633_CR69) 1998; 3 V Baud (633_CR1) 2001; 9 F Bussolino (633_CR107) 1988; 24 R Zhang (633_CR65) 2003; 51 S Haider (633_CR63) 2009; 2 D Faustman (633_CR64) 2010; 6 K Warzocha (633_CR111) 1997; 2 EC Ledgerwood (633_CR29) 1999; 9 R Ksontini (633_CR24) 1998; 5 C Bubici (633_CR94) 2006; 51 T Zhou (633_CR3) 2002; 1–3 KM Deleault (633_CR10) 2008; 1 SCLSC Sun (633_CR61) 2008; 10 G Eissner (633_CR14) 2004; 5 M Riewald (633_CR86) 2003; 2 KS Mark (633_CR75) 2001; 3 M Grell (633_CR36) 1998; 2 G Sethi (633_CR96) 2012; 1 JD Lambeth (633_CR90) 2004; 3 P Mommsen (633_CR83) 2011; 3 JM Li (633_CR93) 2005; 6 JB Cone (633_CR67) 2001; 6 RA Black (633_CR13) 1997; 6618 E Zandi (633_CR46) 1997; 2 Y Wu (633_CR108) 2010; 4 633_CR59 H Rauert (633_CR62) 2010; 10 M Kriegler (633_CR11) 1988; 1 G Bonizzi (633_CR48) 2004; 6 E Dejardin (633_CR43) 2006; 9 D Chappell (633_CR78) 2009; 1 M Jaiswal (633_CR103) 2000; 1 B Beutler (633_CR4) 1998; 10 JR Bradley (633_CR16) 2008; 2 H Hsu (633_CR38) 1996; 2 B Luettig (633_CR12) 1989; 12 SM Santee (633_CR28) 1996; 35 D Gaiotti (633_CR101) 2000; 2 F Balkwill (633_CR99) 2002; 2 AM Chinnaiyan (633_CR55) 1996; 9 MJ Eck (633_CR15) 1989; 29 A Tabernero (633_CR71) 2003; 2 C Denzlinger (633_CR76) 1985; 4723 H Hsu (633_CR39) 1996; 4 ER Sherwood (633_CR68) 2004; 3 L Steinman (633_CR95) 2010; 48 DR Spriggs (633_CR7) 1992; 56 TJ Schall (633_CR26) 1990; 2 G Camussi (633_CR20) 1991; 1 J Wang (633_CR33) 2003; 24 E Duda (633_CR6) 2005 P Neumann (633_CR74) 2004; 2 FC Kischkel (633_CR57) 1995; 22 SR Ruuls (633_CR8) 1999; 2 BB Aggarwal (633_CR100) 2006; 11 633_CR73 H Wajant (633_CR2) 2003; 1 S Yoshida (633_CR104) 1997; 7 FK Chan (633_CR37) 2000; 5475 MM Campos (633_CR81) 1998; 7 E Ulfhammer (633_CR88) 2006; 8 JY Lee (633_CR22) 2003; 6 HT Idriss (633_CR9) 2000; 3 UM Chandrasekharan (633_CR82) 2007; 5 B Beutler (633_CR23) 1986; 4753 A Rahman (633_CR92) 1998; 3 D Tracey (633_CR34) 2008; 2 R Pawlinski (633_CR87) 2003; 10 Y Yamamoto (633_CR49) 2003; 6940 H Kulbe (633_CR110) 2005; 22 MJ Morgan (633_CR89) 2011; 1 JM Kyriakis (633_CR52) 2001; 2 SE Goldblum (633_CR79) 1990; 2 P Szlosarek (633_CR98) 2006; 6 B Kaminska (633_CR53) 2005; 1–2 JF Schindler (633_CR54) 2007; 9 CB Cairns (633_CR19) 2000; 8 S Kumar (633_CR51) 2001; 3 P Vallance (633_CR70) 2001; 3 U Siebenlist (633_CR44) 2005; 6 D Aderka (633_CR31) 1992; 2 KE Sullivan (633_CR21) 2003; 2–3 S Wu (633_CR102) 1993; 8 FR Balkwill (633_CR97) 2012; 1 N Cheng (633_CR105) 2001; 17 PJ Naude (633_CR60) 2011; 6 P Cesaris De (633_CR106) 1999; 41 H Loetscher (633_CR25) 1990; 2 T Hagemann (633_CR109) 2005; 2 E Lin (633_CR18) 2000; 2 A Devin (633_CR45) 2000; 4 DJ Angelini (633_CR80) 2006; 6 M Grell (633_CR35) 1995; 5 Z Zhou (633_CR66) 2008; 4 AH Hajeer (633_CR32) 2000; 3 M Muzio (633_CR58) 1998; 5 1550865 - Immunol Ser. 1992;56:3-34 17068152 - Blood. 2007 Mar 1;109(5):1938-44 10496522 - Lab Invest. 1999 Sep;79(9):1041-50 9645922 - Blood Cells Mol Dis. 1998 Jun;24(2):216-30 10657902 - Mol Carcinog. 2000 Feb;27(2):97-109 12789342 - Nature. 2003 Jun 5;423(6940):655-9 8702885 - J Biol Chem. 1996 Aug 30;271(35):21151-9 9345850 - Trends Pharmacol Sci. 1997 Sep;18(9):319-22 16891393 - Am J Physiol Lung Cell Mol Physiol. 2006 Dec;291(6):L1232-45 8612133 - Immunity. 1996 Apr;4(4):387-96 1689552 - Am J Physiol. 1990 Feb;258(2 Pt 1):L57-67 18632801 - Am J Physiol Renal Physiol. 2008 Oct;295(4):F932-41 10891884 - Microsc Res Tech. 2000 Aug 1;50(3):184-95 4048937 - Science. 1985 Oct 18;230(4723):330-2 1315717 - Genomics. 1992 May;13(1):219-24 21237580 - Pathol Res Pract. 2011 Mar 15;207(3):142-7 10686974 - Surgery. 2000 Feb;127(2):117-26 20087353 - Br J Cancer. 2010 Feb 16;102(4):639-44 10795740 - Immunity. 2000 Apr;12 (4):419-29 12773519 - J Leukoc Biol. 2003 Jun;73(6):862-71 9728048 - Am J Physiol. 1998 Sep;275(3 Pt 1):L533-44 17606294 - Mol Immunol. 2008 Jan;45(1):13-24 12403370 - Immunol Res. 2002;26(1-3):323-36 9199336 - Mol Cell Biol. 1997 Jul;17(7):4015-23 11192310 - Perfusion. 2001 Jan;16(1):67-74 16879221 - J Thromb Haemost. 2006 Aug;4(8):1781-9 16517151 - Eur J Cancer. 2006 Apr;42(6):745-50 11274345 - Physiol Rev. 2001 Apr;81(2):807-69 11278471 - J Biol Chem. 2001 Apr 27;276(17):13771-7 8385577 - Cancer Res. 1993 Apr 15;53(8):1939-44 9053471 - J Clin Oncol. 1997 Feb;15(2):499-508 15039755 - Nat Rev Immunol. 2004 Mar;4(3):181-9 18161752 - J Pathol. 2008 Jan;214(2):149-60 7510950 - Biochem J. 1994 Mar 1;298 ( Pt 2):249-58 2556474 - J Immunol. 1989 Dec 15;143(12):4034-8 3349526 - Cell. 1988 Apr 8;53(1):45-53 9435233 - Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):570-5 2158862 - Cell. 1990 Apr 20;61(2):351-9 11712756 - Curr Opin Pharmacol. 2001 Jun;1(3):307-13 10958139 - Acad Emerg Med. 2000 Aug;7(8):930-41 7888182 - Annu Rev Cell Biol. 1994;10:405-55 10875917 - Science. 2000 Jun 30;288(5475):2351-4 1310100 - J Exp Med. 1992 Feb 1;175(2):323-9 2158863 - Cell. 1990 Apr 20;61(2):361-70 2551905 - J Biol Chem. 1989 Oct 15;264(29):17595-605 9647479 - Br J Pharmacol. 1998 Jun;124(3):540-6 2566060 - Lancet. 1989 May 20;1(8647):1122-6 14555463 - Am J Physiol Lung Cell Mol Physiol. 2004 Feb;286(2):L452-9 9922370 - Physiol Rev. 1999 Jan;79(1):143-80 12857996 - Immunol Res. 2003;27(2-3):529-38 22210179 - Semin Cancer Biol. 2012 Feb;22(1):33-40 9786178 - Peptides. 1998;19(7):1269-76 11080499 - J Biol Chem. 2001 Feb 9;276(6):4494-500 9034190 - Nature. 1997 Feb 20;385(6618):729-33 15450251 - Cytokine Growth Factor Rev. 2004 Oct;15(5):353-66 10506145 - J Biol Chem. 1999 Oct 8;274(41):28978-82 11900989 - Cytokine Growth Factor Rev. 2002 Apr;13(2):135-41 9605921 - Arch Surg. 1998 May;133(5):558-67 18836678 - Basic Res Cardiol. 2009 Jan;104(1):78-89 11514191 - Trends Cell Biol. 2001 Sep;11(9):372-7 16002723 - J Immunol. 2005 Jul 15;175(2):1197-205 15212335 - Best Pract Res Clin Anaesthesiol. 2004 Sep;18(3):385-405 21981137 - Biosci Rep. 2012 Feb;32(1):1-15 8617770 - J Biol Chem. 1996 Mar 1;271(9):4961-5 16889756 - Biochem Pharmacol. 2006 Nov 30;72(11):1605-21 1704649 - Transplantation. 1991 Feb;51(2):537-9 15743827 - Mol Cell Biol. 2005 Mar;25(6):2320-30 12655295 - Cell Death Differ. 2003 Jan;10(1):45-65 9446604 - J Biol Chem. 1998 Jan 30;273(5):2926-30 8521496 - Cell. 1995 Dec 1;83(5):793-802 1657606 - Eur J Biochem. 1991 Nov 15;202(1):3-14 17720847 - J Dent Res. 2007 Sep;86(9):800-11 2570531 - Am J Pathol. 1989 Jul;135(1):203-17 3754653 - Science. 1986 May 23;232(4753):977-80 19027157 - Placenta. 2009 Feb;30(2):111-23 3261295 - J Biol Chem. 1988 Aug 25;263(24):11856-61 2566624 - J Clin Invest. 1989 Jun;83(6):2008-17 21098269 - Proc Natl Acad Sci U S A. 2010 Nov 30;107(48):20595-6 12719729 - Nat Immunol. 2003 May;4(5):404-9 9346241 - Cell. 1997 Oct 17;91(2):243-52 11179281 - Heart. 2001 Mar;85(3):342-50 12360211 - Nat Rev Immunol. 2002 Oct;2(10 ):725-34 7768931 - J Biol Chem. 1995 Jun 2;270(22):13303-7 20038584 - J Biol Chem. 2010 Mar 5;285(10):7394-404 18155297 - Pharmacol Ther. 2008 Feb;117(2):244-79 15905862 - Nat Rev Immunol. 2005 Jun;5(6):435-45 8565075 - Cell. 1996 Jan 26;84(2):299-308 18687299 - Int Immunopharmacol. 2008 Oct;8(10):1377-85 12720558 - Crit Care. 2003 Apr;7(2):123-9 11839317 - Am J Surg. 2001 Dec;182(6):558-62 21187859 - Cell Res. 2011 Jan;21(1):103-15 20489699 - Nat Rev Drug Discov. 2010 Jun;9(6):482-93 8521815 - EMBO J. 1995 Nov 15;14(22):5579-88 12594587 - Intensive Care Med. 2003 Feb;29(2):262-70 11356928 - J Pharmacol Exp Ther. 2001 Jun;297(3):1051-8 12543866 - Blood. 2003 May 15;101(10):3940-7 14532277 - J Biol Chem. 2003 Dec 19;278(51):51267-76 18775672 - Trends Immunol. 2008 Oct;29(10 ):469-78 15145317 - Trends Immunol. 2004 Jun;25(6):280-8 16288025 - Cancer Res. 2005 Nov 15;65(22):10355-62 18063842 - Gen Physiol Biophys. 2007 Sep;26(3):159-67 16970925 - Biochem Pharmacol. 2006 Oct 30;72(9):1161-79 10891887 - Microsc Res Tech. 2000 Aug 1;50(3):216-28 16198162 - Biochim Biophys Acta. 2005 Dec 30;1754(1-2):253-62 17072325 - Oncogene. 2006 Oct 30;25(51):6731-48 10646872 - Cancer Res. 2000 Jan 1;60(1):184-90 21232019 - FEBS J. 2011 Apr;278(6):888-98 10417271 - Am J Hum Genet. 1999 Aug;65(2):294-301 12646554 - J Biol Chem. 2003 Jun 13;278(24):21751-60 |
| References_xml | – volume: 2 start-page: 570 year: 1998 end-page: 575 ident: CR36 article-title: The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor publication-title: Proc Natl Acad Sci USA. doi: 10.1073/pnas.95.2.570 – volume: 1 start-page: 103 year: 2011 end-page: 115 ident: CR89 article-title: Crosstalk of reactive oxygen species and NF-kappaB signaling publication-title: Cell Res doi: 10.1038/cr.2010.178 – volume: 29 start-page: 17595 year: 1989 end-page: 17605 ident: CR15 article-title: The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding publication-title: J Biol Chem – volume: 1 start-page: 78 year: 2009 end-page: 89 ident: CR78 article-title: TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin publication-title: Basic Res Cardiol doi: 10.1007/s00395-008-0749-5 – volume: 2 start-page: 351 year: 1990 end-page: 359 ident: CR25 article-title: Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor publication-title: Cell doi: 10.1016/0092-8674(90)90815-V – volume: 22 start-page: 5579 year: 1995 end-page: 5588 ident: CR57 article-title: Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor publication-title: EMBO J – volume: 8 start-page: 930 year: 2000 end-page: 941 ident: CR19 article-title: Bench to bedside: tumor necrosis factor-alpha: from inflammation to resuscitation publication-title: Acad Emerg Med doi: 10.1111/j.1553-2712.2000.tb02077.x – volume: 5475 start-page: 2351 year: 2000 end-page: 2354 ident: CR37 article-title: A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling publication-title: Science doi: 10.1126/science.288.5475.2351 – volume: 2 start-page: 537 year: 1991 end-page: 539 ident: CR85 article-title: Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts publication-title: Transplantation – volume: 2–3 start-page: 529 year: 2003 end-page: 538 ident: CR21 article-title: Regulation Of Inflammation publication-title: Immunol Res doi: 10.1385/IR:27:2-3:529 – volume: 2 start-page: 299 year: 1996 end-page: 308 ident: CR38 article-title: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways publication-title: Cell doi: 10.1016/S0092-8674(00)80984-8 – volume: 1 start-page: 45 year: 1988 end-page: 53 ident: CR11 article-title: A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF publication-title: Cell doi: 10.1016/0092-8674(88)90486-2 – volume: 10 start-page: 3940 year: 2003 end-page: 3947 ident: CR87 article-title: Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model publication-title: Blood doi: 10.1182/blood-2002-07-2303 – volume: 2 start-page: 262 year: 2003 end-page: 270 ident: CR71 article-title: Cyclooxygenase-2 and inducible nitric oxide synthase in omental arteries harvested from patients with severe liver diseases: immuno-localization and influence on vascular tone publication-title: Intensive Care Med – volume: 2 start-page: 97 year: 2000 end-page: 109 ident: CR101 article-title: Tumornecrosis fact-alpha promotes human papillomavirus (HPV) E6/E7 RNA expression and cyclin- dependent kinase activity in HPV-immortalized keratinocytes by a ras-dependent pathway publication-title: Mol Carcinog doi: 10.1002/(SICI)1098-2744(200002)27:2<97::AID-MC5>3.0.CO;2-V – volume: 1 start-page: 143 year: 1999 end-page: 180 ident: CR50 article-title: Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human publication-title: Physiol Rev – volume: 2 start-page: 111 year: 2009 end-page: 123 ident: CR63 article-title: Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium publication-title: Placenta doi: 10.1016/j.placenta.2008.10.012 – volume: 7 start-page: 1269 year: 1998 end-page: 1276 ident: CR81 article-title: Modulation of kinin B1 but not B2 receptors-mediated rat paw edema by IL-1beta and TNFalpha publication-title: Peptides doi: 10.1016/S0196-9781(98)00087-4 – volume: 3 start-page: 342 year: 2001 end-page: 350 ident: CR70 article-title: Endothelial function and nitric oxide: clinical relevance publication-title: Heart doi: 10.1136/heart.85.3.342 – volume: 22 start-page: 13303 year: 1995 end-page: 13307 ident: CR5 article-title: Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor publication-title: J Biol Chem – volume: 6 start-page: 280 year: 2004 end-page: 288 ident: CR48 article-title: The two NF-kappaB activation pathways and their role in innate and adaptive immunity publication-title: Trends Immunol doi: 10.1016/j.it.2004.03.008 – volume: 4 start-page: 387 year: 1996 end-page: 396 ident: CR39 article-title: TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex publication-title: Immunity doi: 10.1016/S1074-7613(00)80252-6 – volume: 8647 start-page: 1122 year: 1989 end-page: 1126 ident: CR17 article-title: Cachectin/tumour necrosis factor publication-title: Lancet doi: 10.1016/S0140-6736(89)92394-5 – volume: 10 start-page: 1377 year: 2008 end-page: 1385 ident: CR91 article-title: Expression of NADPH oxidases and enhanced H(2)O(2)-generating activity in human coronary artery endothelial cells upon induction with tumor necrosis factor-alpha publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2008.05.004 – volume: 5 start-page: 2926 year: 1998 end-page: 2930 ident: CR58 article-title: An induced proximity model for caspase-8 activation publication-title: J Biol Chem doi: 10.1074/jbc.273.5.2926 – volume: 4753 start-page: 977 year: 1986 end-page: 980 ident: CR23 article-title: Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance publication-title: Science doi: 10.1126/science.3754653 – volume: 12 start-page: 4034 year: 1989 end-page: 4038 ident: CR12 article-title: Evidence for the existence of two forms of membrane tumor necrosis factor: an integral protein and a molecule attached to its receptor publication-title: J Immunol. – volume: 2 start-page: 149 year: 2008 end-page: 160 ident: CR16 article-title: TNF-mediated inflammatory disease publication-title: J Pathol. doi: 10.1002/path.2287 – volume: 2 start-page: 243 year: 1997 end-page: 252 ident: CR46 article-title: The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation publication-title: Cell doi: 10.1016/S0092-8674(00)80406-7 – volume: 6 start-page: L1232 year: 2006 end-page: L1245 ident: CR80 article-title: TNF-alpha increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00109.2006 – volume: 1 start-page: 184 year: 2000 end-page: 190 ident: CR103 article-title: Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependentmechanism publication-title: Cancer Res – volume: 7 start-page: 4015 year: 1997 end-page: 4023 ident: CR104 article-title: Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis publication-title: Mol Cell Biol – volume: 4 start-page: 639 year: 2010 end-page: 644 ident: CR108 article-title: TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion publication-title: Br J Cancer doi: 10.1038/sj.bjc.6605530 – volume: 9 start-page: 1041 year: 1999 end-page: 1050 ident: CR29 article-title: Recent advances in the molecular basis of TNF signal transduction publication-title: Lab Invest – volume: 2 start-page: 244 year: 2008 end-page: 279 ident: CR34 article-title: Tumor necrosis factor antagonist mechanisms of action: a comprehensive review publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2007.10.001 – volume: 9 start-page: 4961 year: 1996 end-page: 4965 ident: CR55 article-title: FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis publication-title: J Biol Chem – volume: 3 start-page: 181 year: 2004 end-page: 189 ident: CR90 article-title: NOX enzymes and the biology of reactive oxygen publication-title: Nat Rev Immunol doi: 10.1038/nri1312 – volume: 5 start-page: 793 year: 1995 end-page: 802 ident: CR35 article-title: The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor publication-title: Cell doi: 10.1016/0092-8674(95)90192-2 – volume: 6 start-page: 862 year: 2003 end-page: 871 ident: CR22 article-title: Histone acetylation and chromatin conformation are regulated separately at the TNF-alpha promoter in monocytes and macrophages publication-title: J Leukoc Biol doi: 10.1189/jlb.1202618 – volume: 9 start-page: 800 year: 2007 end-page: 811 ident: CR54 article-title: p38 pathway kinases as anti-inflammatory drug targets publication-title: J Dent Res – volume: 2 start-page: 1197 year: 2005 end-page: 1205 ident: CR109 article-title: Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK publication-title: J Immunol. – volume: 2 start-page: 123 year: 2003 end-page: 129 ident: CR86 article-title: Science review: role of coagulation protease cascades in sepsis publication-title: Crit Care doi: 10.1186/cc1825 – volume: 1 start-page: 13 year: 2008 end-page: 24 ident: CR10 article-title: Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways publication-title: Mol Immunol doi: 10.1016/j.molimm.2007.05.017 – volume: 5 start-page: 558 year: 1998 end-page: 567 ident: CR24 article-title: Revisiting the role of tumor necrosis factor alpha and the response to surgical injury and inflammation publication-title: Arch Surg doi: 10.1001/archsurg.133.5.558 – volume: 2 start-page: 499 year: 1997 end-page: 508 ident: CR111 article-title: Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients publication-title: J Clin Oncol – volume: 2 start-page: 294 year: 1999 end-page: 301 ident: CR8 article-title: Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal models publication-title: Am J Hum Genet doi: 10.1086/302517 – volume: 3 start-page: 540 year: 1998 end-page: 546 ident: CR69 article-title: Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0701815 – volume: 6 start-page: 745 year: 2006 end-page: 750 ident: CR98 article-title: Tumour necrosis factor-α as a tumour promoter publication-title: Eur J Cancer doi: 10.1016/j.ejca.2006.01.012 – volume: 22 start-page: 10355 year: 2005 end-page: 10362 ident: CR110 article-title: The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-0957 – volume: 51 start-page: 6731 year: 2006 end-page: 6748 ident: CR94 article-title: Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance publication-title: Oncogene doi: 10.1038/sj.onc.1209936 – volume: 6 start-page: 4494 year: 2001 end-page: 4500 ident: CR47 article-title: Role of IKKgamma/nemo in assembly of the Ikappa B kinase complex publication-title: J Biol Chem doi: 10.1074/jbc.M008353200 – volume: 1 start-page: 45 year: 2003 end-page: 65 ident: CR2 article-title: Tumor necrosis factor signaling publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4401189 – volume: 10 start-page: 725 year: 2002 end-page: 734 ident: CR42 article-title: NF-kappaB regulation in the immune system publication-title: Nat Rev Immunol doi: 10.1038/nri910 – ident: CR41 – volume: 1 start-page: 67 year: 2001 end-page: 74 ident: CR72 article-title: Comparison of tumor necrosis factor-alpha effect on the expression of iNOS in macrophage and cardiac myocytes publication-title: Perfusion. doi: 10.1177/026765910101600110 – start-page: 171 year: 2005 end-page: 209 ident: CR6 article-title: Signaling and reverse signaling in the tumor necrosis factor/TNF receptor system publication-title: Biophysical aspects of transmembrane signaling doi: 10.1007/3-540-26511-2_7 – volume: 4 start-page: 419 year: 2000 end-page: 429 ident: CR45 article-title: The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation publication-title: Immunity doi: 10.1016/S1074-7613(00)80194-6 – volume: 2 start-page: 807 year: 2001 end-page: 869 ident: CR52 article-title: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation publication-title: Physiol Rev – volume: 24 start-page: 11856 year: 1988 end-page: 11861 ident: CR107 article-title: Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha publication-title: J Biol Chem – volume: 8 start-page: 1781 year: 2006 end-page: 1789 ident: CR88 article-title: TNF-alpha mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NF-kappaB- and p38 MAPK-dependent publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2006.02035.x – volume: 56 start-page: 3 year: 1992 end-page: 34 ident: CR7 article-title: Genomic structure, induction, and production of TNF-alpha publication-title: Immunol Ser – volume: 10 start-page: 216 year: 1998 end-page: 230 ident: CR4 article-title: TNF, apoptosis and autoimmunity: A common thread? publication-title: Blood Cells Mol Dis doi: 10.1006/bcmd.1998.0187 – volume: 3 start-page: 184 year: 2000 end-page: 195 ident: CR9 article-title: TNF alpha and the TNF receptor superfamily: structure-function relationship(s) publication-title: Microsc Res Tech doi: 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H – volume: 1 start-page: 1 year: 2012 end-page: 15 ident: CR96 article-title: Multifaced link between cancer and inflammation publication-title: Biosci Rep doi: 10.1042/BSR20100136 – volume: 5 start-page: 353 year: 2004 end-page: 366 ident: CR14 article-title: Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system publication-title: Cytokine Growth Factor Rev doi: 10.1016/j.cytogfr.2004.03.011 – volume: 2 start-page: 135 year: 2002 end-page: 141 ident: CR99 article-title: Tumor necrosis factor or tumor promoting factor? publication-title: Cytokine Growth Factor Ref doi: 10.1016/S1359-6101(01)00020-X – volume: 17 start-page: 13771 year: 2001 end-page: 13777 ident: CR105 article-title: Tumor necrosis factor-alpha induction of endothelial ephrin A1 expression is mediated by a p38 MAPK- andSAPK/JNK-dependent but nuclear factor-kappa B-independent mechanism publication-title: J Biol Chem – volume: 3 start-page: L533 issue: Pt 1 year: 1998 end-page: L544 ident: CR92 article-title: E-selectin expression in human endothelial cells by TNF-alpha-induced oxidant generation and NF-kappaB activation publication-title: Am J Physiol – volume: 1 start-page: 219 year: 1992 end-page: 224 ident: CR27 article-title: Structure of the human TNF receptor 1 (p60) gene (TNFR1) and localization to chromosome 12p13 [corrected] publication-title: Genomics doi: 10.1016/0888-7543(92)90226-I – volume: 24 start-page: 21751 year: 2003 end-page: 21760 ident: CR33 article-title: Histamine antagonizes tumor necrosis factor (TNF) signaling by stimulating TNF receptor shedding from the cell surface and Golgi storage pool publication-title: J Biol Chem doi: 10.1074/jbc.M212662200 – volume: 4723 start-page: 330 year: 1985 end-page: 332 ident: CR76 article-title: Leukotrienes as mediators in tissue trauma publication-title: Science doi: 10.1126/science.4048937 – volume: 51 start-page: 51267 year: 2003 end-page: 51276 ident: CR65 article-title: Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway publication-title: J Biol Chem doi: 10.1074/jbc.M310678200 – volume: 2 start-page: 361 year: 1990 end-page: 370 ident: CR26 article-title: Molecular cloning and expression of a receptor for human tumor necrosis factor publication-title: Cell doi: 10.1016/0092-8674(90)90816-W – volume: 35 start-page: 21151 year: 1996 end-page: 21159 ident: CR28 article-title: Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization publication-title: J Biol Chem – volume: 6 start-page: 888 year: 2011 end-page: 898 ident: CR60 article-title: Tumor necrosis factor receptor cross-talk publication-title: FEBS J doi: 10.1111/j.1742-4658.2011.08017.x – volume: 9 start-page: 1161 year: 2006 end-page: 1179 ident: CR43 article-title: The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2006.08.007 – volume: 6618 start-page: 729 year: 1997 end-page: 733 ident: CR13 article-title: A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells publication-title: Nature doi: 10.1038/385729a0 – volume: 1 start-page: 33 year: 2012 end-page: 40 ident: CR97 article-title: Cancer-related inflammation: common themes and therapeutic opportunities publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2011.12.005 – volume: 6 start-page: 2320 year: 2005 end-page: 2330 ident: CR93 article-title: Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4 publication-title: Mol Cell Biol doi: 10.1128/MCB.25.6.2320-2330.2005 – volume: 1–2 start-page: 253 year: 2005 end-page: 262 ident: CR53 article-title: MAPK signalling pathways as molecular targets for anti-inflammatory therapy–from molecular mechanisms to therapeutic benefits publication-title: Biochim Biophys Acta – volume: 6 start-page: 482 year: 2010 end-page: 493 ident: CR64 article-title: TNF receptor 2 pathway: drug target for autoimmune diseases publication-title: Nat Rev Drug Discov. doi: 10.1038/nrd3030 – volume: 3 start-page: 307 year: 2001 end-page: 313 ident: CR51 article-title: Intracellular signaling pathways as a target for the treatment of rheumatoid arthritis publication-title: Curr Opin Pharmacol doi: 10.1016/S1471-4892(01)00054-6 – volume: 11 start-page: 1605 year: 2006 end-page: 1621 ident: CR100 article-title: Inflammation andcancer: how hot is the link? publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2006.06.029 – volume: 9 start-page: 319 year: 1997 end-page: 322 ident: CR40 article-title: Tumour necrosis factor alpha and interleukin 1 signalling: do MAPKK kinases connect it all? publication-title: Trends Pharmacol Sci – volume: 2 start-page: 117 year: 2000 end-page: 126 ident: CR18 article-title: Inflammatory cytokines and cell response in surgery publication-title: Surgery. doi: 10.1067/msy.2000.101584 – volume: 6 start-page: 2008 year: 1989 end-page: 2017 ident: CR84 article-title: Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro publication-title: J Clin Invest. doi: 10.1172/JCI114111 – volume: 2 start-page: 323 year: 1992 end-page: 329 ident: CR31 article-title: Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors publication-title: J Exp Med doi: 10.1084/jem.175.2.323 – volume: 3 start-page: 216 year: 2000 end-page: 228 ident: CR32 article-title: TNF-alpha gene polymorphism: clinical and biological implications publication-title: Microsc Res Tech doi: 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q – volume: 1–3 start-page: 323 year: 2002 end-page: 336 ident: CR3 article-title: Immunobiology of tumor necrosis factor receptor superfamily publication-title: Immunol Res doi: 10.1385/IR:26:1-3:323 – volume: 9 start-page: 372 year: 2001 end-page: 377 ident: CR1 article-title: Signal transduction by tumor necrosis factor and its relatives publication-title: Trends Cell Biol doi: 10.1016/S0962-8924(01)02064-5 – volume: 2 start-page: L57 issue: Pt 1 year: 1990 end-page: L67 ident: CR79 article-title: Tumor necrosis factor-alpha augments pulmonary arterial transendothelial albumin flux in vitro publication-title: Am J Physiol – volume: 3 start-page: 142 year: 2011 end-page: 147 ident: CR83 article-title: van GM. Regulation of L-selectin expression by trauma-relevant cytokines publication-title: Pathol Res Pract doi: 10.1016/j.prp.2010.12.003 – volume: 1 start-page: 203 year: 1989 end-page: 217 ident: CR77 article-title: Roles of histamine, complement and xanthine oxidase in thermal injury of skin publication-title: Am J Pathol – volume: 6 start-page: 558 year: 2001 end-page: 562 ident: CR67 article-title: Inflammation publication-title: Am J Surg doi: 10.1016/S0002-9610(01)00822-4 – volume: 48 start-page: 20595 year: 2010 end-page: 20596 ident: CR95 article-title: Modulation of postoperative cognitive decline via blockade of inflammatory cytokines outside the brain publication-title: Proc Natl Acad Sci USA. doi: 10.1073/pnas.1015282107 – volume: 6 start-page: 435 year: 2005 end-page: 445 ident: CR44 article-title: Control of lymphocyte development by nuclear factor-kappaB publication-title: Nat Rev Immunol doi: 10.1038/nri1629 – volume: 5 start-page: 404 year: 2003 end-page: 409 ident: CR56 article-title: The death effector domain protein family: regulators of cellular homeostasis publication-title: Nat Immunol doi: 10.1038/ni0503-404 – volume: 6940 start-page: 655 year: 2003 end-page: 659 ident: CR49 article-title: Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression publication-title: Nature doi: 10.1038/nature01576 – ident: CR73 – volume: 10 start-page: 7394 year: 2010 end-page: 7404 ident: CR62 article-title: Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2) publication-title: J Biol Chem doi: 10.1074/jbc.M109.037341 – volume: 2 start-page: L452 year: 2004 end-page: L459 ident: CR74 article-title: TNF-alpha induces a decrease in eNOS promoter activity publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00378.2002 – volume: 1 start-page: 3 year: 1991 end-page: 14 ident: CR20 article-title: The molecular action of tumor necrosis factor-alpha publication-title: Eur J Biochem doi: 10.1111/j.1432-1033.1991.tb16337.x – volume: 41 start-page: 28978 year: 1999 end-page: 28982 ident: CR106 article-title: Activation of Jun N-terminal kinase/stress-activated protein kinase pathway by tumor necrosis factor alpha leads to intercellular adhesion molecule-1 expression publication-title: J Biol Chem doi: 10.1074/jbc.274.41.28978 – volume: 3 start-page: 385 year: 2004 end-page: 405 ident: CR68 article-title: Mechanisms of the inflammatory response publication-title: Best Pract Res Clin Anaesthesiol. doi: 10.1016/j.bpa.2003.12.002 – volume: 8 start-page: 1939 year: 1993 end-page: 1944 ident: CR102 article-title: Tumornecrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine inductionof tumor cell proliferation and tumor necrosis factor alpha expression publication-title: Cancer Res – volume: 10 start-page: 469 year: 2008 end-page: 478 ident: CR61 article-title: New insights into NF-kappaB regulation and function publication-title: Trends Immunol doi: 10.1016/j.it.2008.07.003 – volume: 3 start-page: 159 year: 2007 end-page: 167 ident: CR30 article-title: TNF signaling: early events and phosphorylation publication-title: Gen Physiol Biophys – volume: 3 start-page: 1051 year: 2001 end-page: 1058 ident: CR75 article-title: Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells publication-title: J Pharmacol Exp Ther – ident: CR59 – volume: 4 start-page: F932 year: 2008 end-page: F941 ident: CR66 article-title: Role of NF-kappaB and PI 3-kinase/Akt in TNF-alpha-induced cytotoxicity in microvascular endothelial cells publication-title: Am J Physiol Renal Physiol. doi: 10.1152/ajprenal.00066.2008 – volume: 5 start-page: 1938 year: 2007 end-page: 1944 ident: CR82 article-title: Tumor necrosis factor alpha (TNF-alpha) receptor-II is required for TNF-alpha-induced leukocyte-endothelial interaction in vivo publication-title: Blood doi: 10.1182/blood-2006-05-020875 – volume: 4 start-page: 639 year: 2010 ident: 633_CR108 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6605530 – volume: 3 start-page: 142 year: 2011 ident: 633_CR83 publication-title: Pathol Res Pract doi: 10.1016/j.prp.2010.12.003 – volume: 1–3 start-page: 323 year: 2002 ident: 633_CR3 publication-title: Immunol Res doi: 10.1385/IR:26:1-3:323 – volume: 2 start-page: 537 year: 1991 ident: 633_CR85 publication-title: Transplantation – volume: 9 start-page: 1161 year: 2006 ident: 633_CR43 publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2006.08.007 – volume: 5 start-page: 558 year: 1998 ident: 633_CR24 publication-title: Arch Surg doi: 10.1001/archsurg.133.5.558 – volume: 2 start-page: 244 year: 2008 ident: 633_CR34 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2007.10.001 – volume: 1 start-page: 3 year: 1991 ident: 633_CR20 publication-title: Eur J Biochem doi: 10.1111/j.1432-1033.1991.tb16337.x – volume: 6 start-page: L1232 year: 2006 ident: 633_CR80 publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00109.2006 – volume: 51 start-page: 51267 year: 2003 ident: 633_CR65 publication-title: J Biol Chem doi: 10.1074/jbc.M310678200 – volume: 3 start-page: 159 year: 2007 ident: 633_CR30 publication-title: Gen Physiol Biophys – volume: 8 start-page: 1939 year: 1993 ident: 633_CR102 publication-title: Cancer Res – volume: 10 start-page: 3940 year: 2003 ident: 633_CR87 publication-title: Blood doi: 10.1182/blood-2002-07-2303 – volume: 2 start-page: 111 year: 2009 ident: 633_CR63 publication-title: Placenta doi: 10.1016/j.placenta.2008.10.012 – volume: 41 start-page: 28978 year: 1999 ident: 633_CR106 publication-title: J Biol Chem doi: 10.1074/jbc.274.41.28978 – volume: 4 start-page: 419 year: 2000 ident: 633_CR45 publication-title: Immunity doi: 10.1016/S1074-7613(00)80194-6 – volume: 9 start-page: 372 year: 2001 ident: 633_CR1 publication-title: Trends Cell Biol doi: 10.1016/S0962-8924(01)02064-5 – volume: 2 start-page: 123 year: 2003 ident: 633_CR86 publication-title: Crit Care doi: 10.1186/cc1825 – volume: 6940 start-page: 655 year: 2003 ident: 633_CR49 publication-title: Nature doi: 10.1038/nature01576 – volume: 29 start-page: 17595 year: 1989 ident: 633_CR15 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)71533-0 – volume: 8 start-page: 930 year: 2000 ident: 633_CR19 publication-title: Acad Emerg Med doi: 10.1111/j.1553-2712.2000.tb02077.x – volume: 3 start-page: 540 year: 1998 ident: 633_CR69 publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0701815 – volume: 6 start-page: 888 year: 2011 ident: 633_CR60 publication-title: FEBS J doi: 10.1111/j.1742-4658.2011.08017.x – volume: 1 start-page: 184 year: 2000 ident: 633_CR103 publication-title: Cancer Res – volume: 7 start-page: 4015 year: 1997 ident: 633_CR104 publication-title: Mol Cell Biol doi: 10.1128/MCB.17.7.4015 – volume: 1 start-page: 67 year: 2001 ident: 633_CR72 publication-title: Perfusion. doi: 10.1177/026765910101600110 – volume: 17 start-page: 13771 year: 2001 ident: 633_CR105 publication-title: J Biol Chem doi: 10.1074/jbc.M009147200 – volume: 56 start-page: 3 year: 1992 ident: 633_CR7 publication-title: Immunol Ser – volume: 6 start-page: 435 year: 2005 ident: 633_CR44 publication-title: Nat Rev Immunol doi: 10.1038/nri1629 – volume: 22 start-page: 10355 year: 2005 ident: 633_CR110 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-0957 – volume: 8 start-page: 1781 year: 2006 ident: 633_CR88 publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2006.02035.x – volume: 24 start-page: 11856 year: 1988 ident: 633_CR107 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)37865-7 – volume: 10 start-page: 7394 year: 2010 ident: 633_CR62 publication-title: J Biol Chem doi: 10.1074/jbc.M109.037341 – volume: 5 start-page: 793 year: 1995 ident: 633_CR35 publication-title: Cell doi: 10.1016/0092-8674(95)90192-2 – volume: 10 start-page: 216 year: 1998 ident: 633_CR4 publication-title: Blood Cells Mol Dis doi: 10.1006/bcmd.1998.0187 – volume: 4753 start-page: 977 year: 1986 ident: 633_CR23 publication-title: Science doi: 10.1126/science.3754653 – volume: 3 start-page: 385 year: 2004 ident: 633_CR68 publication-title: Best Pract Res Clin Anaesthesiol. doi: 10.1016/j.bpa.2003.12.002 – volume: 2 start-page: 323 year: 1992 ident: 633_CR31 publication-title: J Exp Med doi: 10.1084/jem.175.2.323 – volume: 2 start-page: 1197 year: 2005 ident: 633_CR109 publication-title: J Immunol. doi: 10.4049/jimmunol.175.2.1197 – volume: 3 start-page: 216 year: 2000 ident: 633_CR32 publication-title: Microsc Res Tech doi: 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q – volume: 2 start-page: 351 year: 1990 ident: 633_CR25 publication-title: Cell doi: 10.1016/0092-8674(90)90815-V – volume: 5 start-page: 2926 year: 1998 ident: 633_CR58 publication-title: J Biol Chem doi: 10.1074/jbc.273.5.2926 – volume: 12 start-page: 4034 year: 1989 ident: 633_CR12 publication-title: J Immunol. doi: 10.4049/jimmunol.143.12.4034 – volume: 5 start-page: 353 year: 2004 ident: 633_CR14 publication-title: Cytokine Growth Factor Rev doi: 10.1016/j.cytogfr.2004.03.011 – volume: 6618 start-page: 729 year: 1997 ident: 633_CR13 publication-title: Nature doi: 10.1038/385729a0 – volume: 1 start-page: 203 year: 1989 ident: 633_CR77 publication-title: Am J Pathol – volume: 5 start-page: 404 year: 2003 ident: 633_CR56 publication-title: Nat Immunol doi: 10.1038/ni0503-404 – start-page: 171 volume-title: Biophysical aspects of transmembrane signaling year: 2005 ident: 633_CR6 doi: 10.1007/3-540-26511-2_7 – volume: 2 start-page: 807 year: 2001 ident: 633_CR52 publication-title: Physiol Rev doi: 10.1152/physrev.2001.81.2.807 – volume: 51 start-page: 6731 year: 2006 ident: 633_CR94 publication-title: Oncogene doi: 10.1038/sj.onc.1209936 – volume: 1 start-page: 13 year: 2008 ident: 633_CR10 publication-title: Mol Immunol doi: 10.1016/j.molimm.2007.05.017 – volume: 4723 start-page: 330 year: 1985 ident: 633_CR76 publication-title: Science doi: 10.1126/science.4048937 – volume: 1 start-page: 219 year: 1992 ident: 633_CR27 publication-title: Genomics doi: 10.1016/0888-7543(92)90226-I – volume: 2 start-page: 262 year: 2003 ident: 633_CR71 publication-title: Intensive Care Med doi: 10.1007/s00134-002-1617-7 – volume: 3 start-page: 181 year: 2004 ident: 633_CR90 publication-title: Nat Rev Immunol doi: 10.1038/nri1312 – volume: 2 start-page: 299 year: 1996 ident: 633_CR38 publication-title: Cell doi: 10.1016/S0092-8674(00)80984-8 – volume: 10 start-page: 469 year: 2008 ident: 633_CR61 publication-title: Trends Immunol – volume: 6 start-page: 280 year: 2004 ident: 633_CR48 publication-title: Trends Immunol doi: 10.1016/j.it.2004.03.008 – volume: 1–2 start-page: 253 year: 2005 ident: 633_CR53 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbapap.2005.08.017 – volume: 9 start-page: 319 year: 1997 ident: 633_CR40 publication-title: Trends Pharmacol Sci doi: 10.1016/S0165-6147(97)01097-3 – volume: 7 start-page: 1269 year: 1998 ident: 633_CR81 publication-title: Peptides doi: 10.1016/S0196-9781(98)00087-4 – volume: 6 start-page: 745 year: 2006 ident: 633_CR98 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2006.01.012 – volume: 4 start-page: F932 year: 2008 ident: 633_CR66 publication-title: Am J Physiol Renal Physiol. doi: 10.1152/ajprenal.00066.2008 – volume: 2–3 start-page: 529 year: 2003 ident: 633_CR21 publication-title: Immunol Res doi: 10.1385/IR:27:2-3:529 – volume: 3 start-page: 342 year: 2001 ident: 633_CR70 publication-title: Heart doi: 10.1136/heart.85.3.342 – volume: 4 start-page: 387 year: 1996 ident: 633_CR39 publication-title: Immunity doi: 10.1016/S1074-7613(00)80252-6 – volume: 2 start-page: 294 year: 1999 ident: 633_CR8 publication-title: Am J Hum Genet doi: 10.1086/302517 – volume: 6 start-page: 558 year: 2001 ident: 633_CR67 publication-title: Am J Surg doi: 10.1016/S0002-9610(01)00822-4 – volume: 6 start-page: 4494 year: 2001 ident: 633_CR47 publication-title: J Biol Chem – volume: 2 start-page: L452 year: 2004 ident: 633_CR74 publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00378.2002 – volume: 2 start-page: 117 year: 2000 ident: 633_CR18 publication-title: Surgery. doi: 10.1067/msy.2000.101584 – volume: 2 start-page: 243 year: 1997 ident: 633_CR46 publication-title: Cell doi: 10.1016/S0092-8674(00)80406-7 – volume: 1 start-page: 103 year: 2011 ident: 633_CR89 publication-title: Cell Res doi: 10.1038/cr.2010.178 – volume: 8647 start-page: 1122 year: 1989 ident: 633_CR17 publication-title: Lancet doi: 10.1016/S0140-6736(89)92394-5 – volume: 1 start-page: 143 year: 1999 ident: 633_CR50 publication-title: Physiol Rev doi: 10.1152/physrev.1999.79.1.143 – volume: 6 start-page: 2008 year: 1989 ident: 633_CR84 publication-title: J Clin Invest. doi: 10.1172/JCI114111 – volume: 1 start-page: 45 year: 2003 ident: 633_CR2 publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4401189 – volume: 2 start-page: 97 year: 2000 ident: 633_CR101 publication-title: Mol Carcinog doi: 10.1002/(SICI)1098-2744(200002)27:2<97::AID-MC5>3.0.CO;2-V – volume: 2 start-page: 149 year: 2008 ident: 633_CR16 publication-title: J Pathol. doi: 10.1002/path.2287 – volume: 9 start-page: 1041 year: 1999 ident: 633_CR29 publication-title: Lab Invest – volume: 5 start-page: 1938 year: 2007 ident: 633_CR82 publication-title: Blood doi: 10.1182/blood-2006-05-020875 – volume: 6 start-page: 482 year: 2010 ident: 633_CR64 publication-title: Nat Rev Drug Discov. doi: 10.1038/nrd3030 – volume: 2 start-page: 135 year: 2002 ident: 633_CR99 publication-title: Cytokine Growth Factor Ref doi: 10.1016/S1359-6101(01)00020-X – volume: 9 start-page: 800 year: 2007 ident: 633_CR54 publication-title: J Dent Res doi: 10.1177/154405910708600902 – volume: 1 start-page: 78 year: 2009 ident: 633_CR78 publication-title: Basic Res Cardiol doi: 10.1007/s00395-008-0749-5 – volume: 24 start-page: 21751 year: 2003 ident: 633_CR33 publication-title: J Biol Chem doi: 10.1074/jbc.M212662200 – volume: 1 start-page: 45 year: 1988 ident: 633_CR11 publication-title: Cell doi: 10.1016/0092-8674(88)90486-2 – volume: 9 start-page: 4961 year: 1996 ident: 633_CR55 publication-title: J Biol Chem doi: 10.1074/jbc.271.9.4961 – volume: 22 start-page: 13303 year: 1995 ident: 633_CR5 publication-title: J Biol Chem doi: 10.1074/jbc.270.22.13303 – volume: 6 start-page: 862 year: 2003 ident: 633_CR22 publication-title: J Leukoc Biol doi: 10.1189/jlb.1202618 – volume: 48 start-page: 20595 year: 2010 ident: 633_CR95 publication-title: Proc Natl Acad Sci USA. doi: 10.1073/pnas.1015282107 – volume: 1 start-page: 1 year: 2012 ident: 633_CR96 publication-title: Biosci Rep doi: 10.1042/BSR20100136 – ident: 633_CR73 doi: 10.1042/bj2980249 – volume: 3 start-page: 1051 year: 2001 ident: 633_CR75 publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(24)29632-4 – volume: 2 start-page: 499 year: 1997 ident: 633_CR111 publication-title: J Clin Oncol doi: 10.1200/JCO.1997.15.2.499 – volume: 10 start-page: 725 year: 2002 ident: 633_CR42 publication-title: Nat Rev Immunol doi: 10.1038/nri910 – ident: 633_CR41 doi: 10.1146/annurev.cb.10.110194.002201 – volume: 5475 start-page: 2351 year: 2000 ident: 633_CR37 publication-title: Science doi: 10.1126/science.288.5475.2351 – volume: 3 start-page: 307 year: 2001 ident: 633_CR51 publication-title: Curr Opin Pharmacol doi: 10.1016/S1471-4892(01)00054-6 – volume: 3 start-page: L533 issue: Pt 1 year: 1998 ident: 633_CR92 publication-title: Am J Physiol – volume: 1 start-page: 33 year: 2012 ident: 633_CR97 publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2011.12.005 – ident: 633_CR59 doi: 10.1007/978-1-59259-963-9_72 – volume: 3 start-page: 184 year: 2000 ident: 633_CR9 publication-title: Microsc Res Tech doi: 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H – volume: 2 start-page: 361 year: 1990 ident: 633_CR26 publication-title: Cell doi: 10.1016/0092-8674(90)90816-W – volume: 11 start-page: 1605 year: 2006 ident: 633_CR100 publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2006.06.029 – volume: 2 start-page: 570 year: 1998 ident: 633_CR36 publication-title: Proc Natl Acad Sci USA. doi: 10.1073/pnas.95.2.570 – volume: 2 start-page: L57 issue: Pt 1 year: 1990 ident: 633_CR79 publication-title: Am J Physiol – volume: 22 start-page: 5579 year: 1995 ident: 633_CR57 publication-title: EMBO J doi: 10.1002/j.1460-2075.1995.tb00245.x – volume: 6 start-page: 2320 year: 2005 ident: 633_CR93 publication-title: Mol Cell Biol – volume: 10 start-page: 1377 year: 2008 ident: 633_CR91 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2008.05.004 – volume: 35 start-page: 21151 year: 1996 ident: 633_CR28 publication-title: J Biol Chem doi: 10.1074/jbc.271.35.21151 – reference: 16889756 - Biochem Pharmacol. 2006 Nov 30;72(11):1605-21 – reference: 2158862 - Cell. 1990 Apr 20;61(2):351-9 – reference: 2158863 - Cell. 1990 Apr 20;61(2):361-70 – reference: 10417271 - Am J Hum Genet. 1999 Aug;65(2):294-301 – reference: 12789342 - Nature. 2003 Jun 5;423(6940):655-9 – reference: 1310100 - J Exp Med. 1992 Feb 1;175(2):323-9 – reference: 16517151 - Eur J Cancer. 2006 Apr;42(6):745-50 – reference: 18775672 - Trends Immunol. 2008 Oct;29(10 ):469-78 – reference: 8612133 - Immunity. 1996 Apr;4(4):387-96 – reference: 18836678 - Basic Res Cardiol. 2009 Jan;104(1):78-89 – reference: 17072325 - Oncogene. 2006 Oct 30;25(51):6731-48 – reference: 15450251 - Cytokine Growth Factor Rev. 2004 Oct;15(5):353-66 – reference: 15743827 - Mol Cell Biol. 2005 Mar;25(6):2320-30 – reference: 18155297 - Pharmacol Ther. 2008 Feb;117(2):244-79 – reference: 18632801 - Am J Physiol Renal Physiol. 2008 Oct;295(4):F932-41 – reference: 11514191 - Trends Cell Biol. 2001 Sep;11(9):372-7 – reference: 8521496 - Cell. 1995 Dec 1;83(5):793-802 – reference: 7888182 - Annu Rev Cell Biol. 1994;10:405-55 – reference: 11900989 - Cytokine Growth Factor Rev. 2002 Apr;13(2):135-41 – reference: 9922370 - Physiol Rev. 1999 Jan;79(1):143-80 – reference: 10496522 - Lab Invest. 1999 Sep;79(9):1041-50 – reference: 12720558 - Crit Care. 2003 Apr;7(2):123-9 – reference: 15905862 - Nat Rev Immunol. 2005 Jun;5(6):435-45 – reference: 12543866 - Blood. 2003 May 15;101(10):3940-7 – reference: 11179281 - Heart. 2001 Mar;85(3):342-50 – reference: 12773519 - J Leukoc Biol. 2003 Jun;73(6):862-71 – reference: 10875917 - Science. 2000 Jun 30;288(5475):2351-4 – reference: 12594587 - Intensive Care Med. 2003 Feb;29(2):262-70 – reference: 18687299 - Int Immunopharmacol. 2008 Oct;8(10):1377-85 – reference: 17720847 - J Dent Res. 2007 Sep;86(9):800-11 – reference: 10891887 - Microsc Res Tech. 2000 Aug 1;50(3):216-28 – reference: 9053471 - J Clin Oncol. 1997 Feb;15(2):499-508 – reference: 17068152 - Blood. 2007 Mar 1;109(5):1938-44 – reference: 14532277 - J Biol Chem. 2003 Dec 19;278(51):51267-76 – reference: 2551905 - J Biol Chem. 1989 Oct 15;264(29):17595-605 – reference: 16288025 - Cancer Res. 2005 Nov 15;65(22):10355-62 – reference: 10657902 - Mol Carcinog. 2000 Feb;27(2):97-109 – reference: 12360211 - Nat Rev Immunol. 2002 Oct;2(10 ):725-34 – reference: 10891884 - Microsc Res Tech. 2000 Aug 1;50(3):184-95 – reference: 10795740 - Immunity. 2000 Apr;12 (4):419-29 – reference: 8385577 - Cancer Res. 1993 Apr 15;53(8):1939-44 – reference: 21232019 - FEBS J. 2011 Apr;278(6):888-98 – reference: 9345850 - Trends Pharmacol Sci. 1997 Sep;18(9):319-22 – reference: 9645922 - Blood Cells Mol Dis. 1998 Jun;24(2):216-30 – reference: 8617770 - J Biol Chem. 1996 Mar 1;271(9):4961-5 – reference: 21098269 - Proc Natl Acad Sci U S A. 2010 Nov 30;107(48):20595-6 – reference: 16198162 - Biochim Biophys Acta. 2005 Dec 30;1754(1-2):253-62 – reference: 12646554 - J Biol Chem. 2003 Jun 13;278(24):21751-60 – reference: 9346241 - Cell. 1997 Oct 17;91(2):243-52 – reference: 18161752 - J Pathol. 2008 Jan;214(2):149-60 – reference: 8702885 - J Biol Chem. 1996 Aug 30;271(35):21151-9 – reference: 15212335 - Best Pract Res Clin Anaesthesiol. 2004 Sep;18(3):385-405 – reference: 21187859 - Cell Res. 2011 Jan;21(1):103-15 – reference: 11080499 - J Biol Chem. 2001 Feb 9;276(6):4494-500 – reference: 9034190 - Nature. 1997 Feb 20;385(6618):729-33 – reference: 7768931 - J Biol Chem. 1995 Jun 2;270(22):13303-7 – reference: 10506145 - J Biol Chem. 1999 Oct 8;274(41):28978-82 – reference: 21237580 - Pathol Res Pract. 2011 Mar 15;207(3):142-7 – reference: 21981137 - Biosci Rep. 2012 Feb;32(1):1-15 – reference: 12655295 - Cell Death Differ. 2003 Jan;10(1):45-65 – reference: 11274345 - Physiol Rev. 2001 Apr;81(2):807-69 – reference: 19027157 - Placenta. 2009 Feb;30(2):111-23 – reference: 11839317 - Am J Surg. 2001 Dec;182(6):558-62 – reference: 17606294 - Mol Immunol. 2008 Jan;45(1):13-24 – reference: 18063842 - Gen Physiol Biophys. 2007 Sep;26(3):159-67 – reference: 7510950 - Biochem J. 1994 Mar 1;298 ( Pt 2):249-58 – reference: 2566624 - J Clin Invest. 1989 Jun;83(6):2008-17 – reference: 11278471 - J Biol Chem. 2001 Apr 27;276(17):13771-7 – reference: 20087353 - Br J Cancer. 2010 Feb 16;102(4):639-44 – reference: 14555463 - Am J Physiol Lung Cell Mol Physiol. 2004 Feb;286(2):L452-9 – reference: 1704649 - Transplantation. 1991 Feb;51(2):537-9 – reference: 8565075 - Cell. 1996 Jan 26;84(2):299-308 – reference: 16970925 - Biochem Pharmacol. 2006 Oct 30;72(9):1161-79 – reference: 12403370 - Immunol Res. 2002;26(1-3):323-36 – reference: 12857996 - Immunol Res. 2003;27(2-3):529-38 – reference: 15145317 - Trends Immunol. 2004 Jun;25(6):280-8 – reference: 20038584 - J Biol Chem. 2010 Mar 5;285(10):7394-404 – reference: 2556474 - J Immunol. 1989 Dec 15;143(12):4034-8 – reference: 10958139 - Acad Emerg Med. 2000 Aug;7(8):930-41 – reference: 3754653 - Science. 1986 May 23;232(4753):977-80 – reference: 20489699 - Nat Rev Drug Discov. 2010 Jun;9(6):482-93 – reference: 1315717 - Genomics. 1992 May;13(1):219-24 – reference: 12719729 - Nat Immunol. 2003 May;4(5):404-9 – reference: 3349526 - Cell. 1988 Apr 8;53(1):45-53 – reference: 9786178 - Peptides. 1998;19(7):1269-76 – reference: 10686974 - Surgery. 2000 Feb;127(2):117-26 – reference: 9647479 - Br J Pharmacol. 1998 Jun;124(3):540-6 – reference: 3261295 - J Biol Chem. 1988 Aug 25;263(24):11856-61 – reference: 16891393 - Am J Physiol Lung Cell Mol Physiol. 2006 Dec;291(6):L1232-45 – reference: 11356928 - J Pharmacol Exp Ther. 2001 Jun;297(3):1051-8 – reference: 22210179 - Semin Cancer Biol. 2012 Feb;22(1):33-40 – reference: 9435233 - Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):570-5 – reference: 9199336 - Mol Cell Biol. 1997 Jul;17(7):4015-23 – reference: 1657606 - Eur J Biochem. 1991 Nov 15;202(1):3-14 – reference: 4048937 - Science. 1985 Oct 18;230(4723):330-2 – reference: 9446604 - J Biol Chem. 1998 Jan 30;273(5):2926-30 – reference: 11712756 - Curr Opin Pharmacol. 2001 Jun;1(3):307-13 – reference: 11192310 - Perfusion. 2001 Jan;16(1):67-74 – reference: 9605921 - Arch Surg. 1998 May;133(5):558-67 – reference: 16879221 - J Thromb Haemost. 2006 Aug;4(8):1781-9 – reference: 2570531 - Am J Pathol. 1989 Jul;135(1):203-17 – reference: 16002723 - J Immunol. 2005 Jul 15;175(2):1197-205 – reference: 1550865 - Immunol Ser. 1992;56:3-34 – reference: 8521815 - EMBO J. 1995 Nov 15;14(22):5579-88 – reference: 15039755 - Nat Rev Immunol. 2004 Mar;4(3):181-9 – reference: 10646872 - Cancer Res. 2000 Jan 1;60(1):184-90 – reference: 1689552 - Am J Physiol. 1990 Feb;258(2 Pt 1):L57-67 – reference: 9728048 - Am J Physiol. 1998 Sep;275(3 Pt 1):L533-44 – reference: 2566060 - Lancet. 1989 May 20;1(8647):1122-6 |
| SSID | ssj0008282 |
| Score | 2.568098 |
| SecondaryResourceType | review_article |
| Snippet | Introduction
Inflammation is a very important part of innate immunity and is regulated in many steps. One such regulating step is the cytokine network, where... Inflammation is a very important part of innate immunity and is regulated in many steps. One such regulating step is the cytokine network, where tumor necrosis... Introduction: Inflammation is a very important part of innate immunity and is regulated in many steps. One such regulating step is the cytokine network, where... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 641 |
| SubjectTerms | Allergology Biomedical and Life Sciences Biomedicine Dermatology Humans Immunology Inflammation - immunology Neurology Pharmacology/Toxicology Receptors, Tumor Necrosis Factor - immunology Review Rheumatology Tumor Necrosis Factor-alpha - immunology |
| Title | TNF-α signalling and inflammation: interactions between old acquaintances |
| URI | https://link.springer.com/article/10.1007/s00011-013-0633-0 https://www.ncbi.nlm.nih.gov/pubmed/23685857 https://www.proquest.com/docview/1367879950 https://www.proquest.com/docview/1412504348 |
| Volume | 62 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9tAEB7yuPRS8ujDTWK2UHJosyCvVlptbnawG1JqTLHBPYl9noKcRvYhPyt_JL8p-5AUQtpAL9qDVtIyM9qZYeb7FuCLDVFrIjBlhcY0YwTzgmjMJdE2oZaJAB_7Oc0vF_RqmS0bHHfddru3JcmwU3dgtxC-4HgaQeou27CbudTd93EtyLDbfl0KEUucJMUu_epKmX97xXNn9CLCfFEdDU5nsgdvm2gRDaN692HLVAdwOot003dnaP6EnqrP0CmaPRFR3x3C1Xw6wQ_3yPdoiMC9jUSlkbMpZwYRsniOPF_EbUQ31Kjp2kKra42E-rMR7q43i_odLCbj-cUlbs5OwCplbI1Fnss0SbS0XCoqtdSFVURw6xz6wLqgUBJVKCm44jpVA82NHmglWSKpocyw9D3sVKvKfASks9Sq3PBEqdy5srww2mSWcGFI7pGrPUhaIZaqIRb351tclx0lcpB76eReermXSQ--do_cRFaN1yZ_bjVTOtv3BQ1RmdWmLj3dXOEZ7V6bQweBpY0WPfgQ1dp9kkT2fdaDb62ey-YXrv-9nk__NfsI3pBgcL7D9xh21rcbc-LimLXswzZbsj7sDiej0dSP33__GLtxNJ7OfvWDVT8CX-rvCQ |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB5ROMClKqXQpZQaqeIAWMo63jjmhhCrLYUVh12Jm-XnaZVtye6Bn8Uf4TfhRxJU8ZB6ySV2Es1MPJ81830G-Okias0kpqw0mA4YwbwkBnNFjMuoYzLSx67HxWhKL28Htw2Pu2673duSZFypO7JbhC84nUaQ-8sHWPNYoAyhPCVn3fLrtxCpxEly7LdfXSnztUf8m4xeIMwX1dGYdIaf4GODFtFZcu8mrNjqMxzeJLnp-xM0eWZP1SfoEN08C1Hfb8HlZDzEjw8o9GjIqL2NZGWQjykfBomyeIqCXsRdYjfUqOnaQvOZQVL_XUp_N4RF_QWmw4vJ-Qg3ZydgnTO2wLIoVJ5lRjmuNFVGmdJpIrnzCb3vPChURJdaSa65yXXfcGv6RiuWKWopsyzfhtVqXtmvgMwgd7qwPNO68KmsKK2xA0e4tKQIzNUeZK0RhW6ExcP5FjPRSSJHuwtvdxHsLrIeHHVT_iRVjfcGH7SeET72Q0FDVna-rEWQmyuDot17Y2g_qrTRsgc7ya3dK0lS32c9OG79LJpfuH77e3b_a_QPWB9Nrq_E1a_x72-wQWLwhW7fPVhd3C3td49pFmo_xvAT3XTsaw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB61VKq4IAotLI9ipIpDwSLreOOYG2q74tGu9rArcbP8PKEskN0DP4s_wm_CjySogiL1kkvGSTQzzow1830D8M3FrDWTmLLSYDpgBPOSGMwVMS6jjskIH_szKs6m9OJqcNXMOa3bbve2JJkwDYGlqZof3xh33AHfYiqD02SC3F_ewwcawMDeoafktPsV--NEKneSHPujWFfWfO0RfwemF9nmi0ppDEDDVVhpMkd0mkz9Cd7Zag0Oxol6-v4ITZ6RVPUROkDjZ1Lq-3W4mIyG-PEBhX4NGXm4kawM8v7lXSLBF09Q4I64S0iHGjUdXGh2bZDUtwvp7wYXqT_DdPhr8uMMN3MUsM4Zm2NZFCrPMqMcV5oqo0zpNJHc-eDedz5BVESXWkmuucl133Br-kYrlilqKbMs_wJL1ayym4DMIHe6sDzTuvBhrSitsQNHuLSkCCjWHmStEoVuSMbDrItr0dEjR70Lr3cR9C6yHnzvltwkho23hPdbywi_D0JxQ1Z2tqhFoJ4rA7vdWzK0HxnbaNmDjWTW7pUkMfGzHhy2dhbNdq7__T1b_yW9Bx_HP4fi9_nochuWSfS90Pi7A0vzu4Xd9enNXH2NLvwEXfzwng |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TNF-%CE%B1+signalling+and+inflammation%3A+interactions+between+old+acquaintances&rft.jtitle=Inflammation+research&rft.au=Zelov%C3%A1%2C+Hana&rft.au=Ho%C5%A1ek%2C+Jan&rft.date=2013-07-01&rft.issn=1420-908X&rft.eissn=1420-908X&rft.volume=62&rft.issue=7&rft.spage=641&rft_id=info:doi/10.1007%2Fs00011-013-0633-0&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1023-3830&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1023-3830&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1023-3830&client=summon |